
(
  (S
    (NP (DT The) (NN Ews-ERG) (NN Fusion) (NN Protein))
    (VP (MD Can)
      (VP (VB Initiate)
        (NP (NN Neoplasia))
        (PP (IN from)
          (NP (JJ Lineage-Committed) (JJ Haematopoietic) (NNS Cells)))))))

(
  (S
    (NP (NN Abstract))))

(
  (S
    (S
      (NP (DT The) (NN EWS-ERG) (NN fusion) (NN protein))
      (VP (VBZ is)
        (VP (VBN found)
          (PP (IN in)
            (NP
              (NP (JJ human) (NNS sarcomas))
              (PP (IN with)
                (NP (DT the) (JJ chromosomal) (NN translocation)
                  (NP
                    (NP (NN t) (-LRB- -LRB-) (CD 21) (: ;) (CD 22) (-RRB- -RRB-))
                    (PRN (-LRB- -LRB-)
                      (NP (CD q22) (: ;) (CD q12))
                      (-RRB- -RRB-)))
                  (, ,)
                  (SBAR
                    (WHADVP (WRB where))
                    (S
                      (NP (DT the) (NN translocation))
                      (VP (VBZ is)
                        (VP (VBN considered)
                          (S
                            (VP (TO to)
                              (VP (VB be)
                                (NP
                                  (NP (DT an) (VBG initiating) (NN event))
                                  (PP (IN in)
                                    (NP (NN sarcoma) (NN formation))))
                                (PP (IN within)
                                  (NP (JJ uncommitted) (JJ mesenchymal) (NNS cells)))
                                (, ,)
                                (ADVP (RB probably))
                                (NP
                                  (NP (JJ long-lived) (NNS progenitors))
                                  (ADJP (JJ capable)
                                    (PP (IN of)
                                      (NP (NN self) (NN renewal)))))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN fusion) (NN protein))
      (VP (MD may) (RB not)
        (ADVP (RB therefore))
        (VP (VB have)
          (NP (DT an) (JJ oncogenic) (NN capability))
          (PP (IN beyond)
            (NP (DT these) (NNS progenitors))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB assess)
            (SBAR (IN whether)
              (S
                (NP (NN EWS-ERG))
                (VP (MD can)
                  (VP (VB be)
                    (NP
                      (NP (DT a) (NN tumour) (NN initiator))
                      (PP (IN in)
                        (NP
                          (NP (NNS cells))
                          (CONJP (JJ other) (IN than))
                          (NP (JJ mesenchymal) (NNS cells))))))))))))
      (, ,)
      (S
        (NP (PRP we))
        (VP (VBP have)
          (VP (VBN analysed)
            (NP
              (NP (NN Ews-ERG) (NN fusion) (NN protein))
              (NN function))
            (PP (IN in)
              (NP
                (NP (DT a) (JJ cellular) (NN environment))
                (ADJP (RB not) (JJ typical)
                  (PP (IN of)
                    (NP
                      (NP (DT that))
                      (VP (VBN found)
                        (PP (IN in)
                          (NP
                            (NP (JJ human) (NNS cancers))
                            (, ,)
                            (ADVP (RB namely))
                            (, ,)
                            (NP (VBN committed) (JJ lymphoid) (NNS cells))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (VP (VBN used)
          (NP
            (NP (NN Ews-ERG) (NN invertor) (NNS mice))
            (VP (VBG having)
              (NP
                (NP (DT an) (JJ inverted) (NN ERG) (NN cDNA) (NN cassette))
                (VP (VBN flanked)
                  (PP (IN by)
                    (NP
                      (NP (JJ loxP) (NNS sites))
                      (VP (VBD knocked)
                        (PP (IN in)
                          (NP (DT the) (NN Ews) (NN intron) (CD 8)))))))))
            (, ,)
            (VP (VBN crossed)
              (PP (IN with)
                (NP
                  (NP (NNS mice))
                  (VP (VBG expressing)
                    (NP (NN Cre) (NN recombinase))
                    (PP (IN under)
                      (NP
                        (NP (DT the) (NN control))
                        (PP (IN of)
                          (NP (DT the) (NN Rag1) (NN gene)))
                        (S
                          (VP (TO to)
                            (VP (VB give)
                              (NP
                                (NP (JJ conditional) (, ,) (JJ lymphoid-specific) (NN expression))
                                (PP (IN of)
                                  (NP (DT the) (NN fusion) (NN protein)))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Clonal) (NN T) (NN cell) (NNS neoplasias))
      (VP (VBP arose)
        (PP (IN in)
          (NP (DT these) (NNS mice)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT This) (JJ conditional) (NN Ews) (NN gene) (NN fusion) (NN model))
        (PP (IN of)
          (NP (NN tumourigenesis))))
      (VP (VBZ shows)
        (SBAR (IN that)
          (S
            (S
              (NP (NN Ews-ERG))
              (VP (MD can)
                (VP (VB cause)
                  (NP (JJ haematopoietic) (NNS tumours)))))
            (CC and)
            (S
              (NP (DT the) (NN precursor) (NNS cells))
              (VP (VBP are)
                (NP (VBN committed) (NNS cells))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (NP (NN Ews-ERG))
      (VP (MD can)
        (VP (VB function)
          (PP (IN in)
            (NP
              (NP (NNS cells))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBP do) (RB not)
                    (VP (VB have)
                      (S
                        (VP (TO to)
                          (VP (VB be)
                            (NP
                              (NP (JJ pluripotent) (NNS progenitors))
                              (CC or)
                              (NP (JJ mesenchymal) (NNS cells)))))))))))))))
    (. .)))

(
  (S
    (NP (NN Introduction))))

(
  (S
    (S
      (NP (JJ Chromosomal) (NNS translocations))
      (VP
        (VP (VBP are)
          (ADJP (JJ characteristic)
            (PP (IN of)
              (NP (JJ many) (JJ human) (NNS cancers)))))
        (, ,)
        (CC and)
        (VP (VBP are)
          (ADVP (RB especially) (RB well))
          (VP (VBN studied)
            (PP (IN in)
              (NP
                (NP (NNS leukaemias))
                (, ,)
                (NP (NNS lymphomas))
                (, ,)
                (CC and)
                (NP (NNS sarcomas))
                (NP (NN -LSB-1,2) (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (JJ Epithelial) (NNS tumours))
        (ADVP (RB also))
        (VP (VBP carry)
          (NP (JJ chromosomal) (NNS translocations))))
      (, ,)
      (CC but)
      (S
        (SBAR (IN while)
          (S
            (NP
              (NP (DT those))
              (PP (IN in)
                (NP
                  (NP (NNS leukaemias))
                  (, ,)
                  (NP (NNS lymphomas))
                  (, ,)
                  (CC and)
                  (NP (NNS sarcomas)))))
            (VP (VBP tend)
              (S
                (VP (TO to)
                  (VP (VB be)
                    (NP (JJ reciprocal) (NNS translocations))))))))
        (, ,)
        (NP
          (NP (DT those))
          (PP (IN in)
            (NP (NNS carcinomas))))
        (VP (VBP are)
          (ADVP (RB often))
          (NP
            (NP (JJ non-reciprocal) (NNS translocations))
            (CD -LSB-3) (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ main) (NNS outcomes))
        (PP (IN of)
          (NP (DT the) (JJ reciprocal) (NNS translocations))))
      (VP (VBP are)
        (NP (CC either)
          (NP
            (NP (VBN forced) (NN oncogene) (NN expression))
            (PRN (, ,)
              (SBAR (IN as)
                (S
                  (VP (VBN found)
                    (PP (IN in)
                      (NP (JJ lymphoid) (NNS malignancies))))))
              (, ,)))
          (CC or)
          (NP
            (NP (NN gene) (NN fusion))
            (, ,)
            (VP (VBN found)
              (PP (IN in)
                (NP (CC both)
                  (NP (NNS leukaemias))
                  (CC and)
                  (NP (NNS sarcomas))))))
          (NP (NN -LSB-1,2))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP (NN Gene) (NN fusion))
      (VP (VBZ occurs)
        (SBAR
          (WHADVP (WRB when))
          (S
            (NP (DT the) (NN translocation) (NNS breakpoints))
            (VP
              (VP (VBP are)
                (PP (IN within)
                  (NP
                    (NP
                      (NP (DT the) (NNS introns))
                      (PP (IN of)
                        (NP (NNS genes))))
                    (, ,)
                    (NP
                      (NP (JJ such))
                      (SBAR (IN that)
                        (S
                          (NP (DT the) (CD two) (VBN translocated) (NNS chromosomes))
                          (VP (VBP have)
                            (NP (JJ new) (NN exon) (NN organisation))))))))
                (, ,)
                (S
                  (VP (VBG leading)
                    (PP (TO to)
                      (NP
                        (NP (DT the) (NN formation))
                        (PP (IN of)
                          (NP (JJ chimaeric) (NN mRNA) (NNS species))))))))
              (CC and)
              (, ,)
              (PP (IN in)
                (NP (NN turn)))
              (, ,)
              (NP (JJ chimaeric) (NNS proteins)))))))
    (. .)))

(
  (S
    (S
      (NP (DT Some) (NNS translocations))
      (VP (MD must)
        (VP (VB function)
          (PP (IN within)
            (NP (NN stem) (NNS cells)))
          (S
            (VP (TO to)
              (VP (VB initiate)
                (NP (NN disease))
                (SBAR (IN while)
                  (S
                    (NP (NNS others))
                    (VP (VBP function)
                      (PP (IN in)
                        (NP (CC both)
                          (NP (NN stem) (NNS cells))
                          (CC and)
                          (NP
                            (ADJP (RBR more) (VBN committed))
                            (NNS cells))))
                      (S
                        (VP (TO to)
                          (VP (VB provide)
                            (NP
                              (NP
                                (ADJP
                                  (ADJP (JJ related))
                                  (CC or)
                                  (ADJP (JJ distinct)))
                                (NNS functions))
                              (PRN (-LRB- -LRB-)
                                (VP (VBN reviewed)
                                  (PP (IN in)
                                    (NP (NN -LSB-4))))
                                (-RRB- -RSB-) (-RRB- -RRB-)))))))))))))))
    (. .)))

(
  (S
    (NP (JJ Different) (NN tumour) (NNS phenotypes))
    (VP (MD can)
      (VP (VB result)
        (PP (IN from)
          (NP
            (NP (JJ specific) (NNS versions))
            (PP (IN of)
              (NP (JJ related) (NN fusion) (NNS proteins)))))
        (PRN (, ,)
          (S
            (S
              (PP (IN for)
                (NP (NN instance)))
              (, ,)
              (NP
                (NP (DT the)
                  (NP
                    (NP (NN Philadelphia) (NN t))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 9) (: ;) (CD 22))
                      (-RRB- -RRB-)))
                  (NN translocation))
                (-LRB- -LRB-)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (VBZ yields)
                      (NP (DT the) (NN BCR-ABL) (JJ -LSB-breakpoint) (NN cluster) (NN region) (NN gene–Abelson) (NN leukaemia) (NN oncogene) (-RRB- -RSB-) (NN fusion)))))
                (-RRB- -RRB-))
              (VP (VBZ occurs)
                (PP (IN in)
                  (NP
                    (ADJP (CC both)
                      (ADJP (JJ myeloid-))
                      (CC and)
                      (ADJP (JJ lymphoid-lineage)))
                    (NNS tumours)))))
            (, ,)
            (S
              (VP (VBN dictated)
                (PP (IN by)
                  (NP
                    (NP (DT the) (NN position))
                    (PP (IN of)
                      (NP (DT the) (NN translocation) (NN junction)))
                    (PP (IN within)
                      (NP (DT the) (NN BCR) (NN gene) (NN -LSB-5))))))))
          (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ biological) (NNS consequences))
        (PP (IN of)
          (NP (DT the) (NN BCR-ABL) (NN fusion))))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN studied)
            (PP (IN in)
              (NP
                (NP (NN relation))
                (PP (TO to)
                  (NP (NN stem) (NN cell) (NNS properties)
                    (NP (CD -LSB-6–8)))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (NP (DT These) (NNS studies))
    (VP (VBP show)
      (SBAR (IN that)
        (S
          (S
            (NP (DT the) (NN BCR-ABL) (NN fusion) (NN protein))
            (VP (VBZ does) (RB not)
              (VP (VB confer)
                (NP (JJ self-renewal) (NN potential))
                (PP (IN on)
                  (NP (VBN committed) (JJ myeloid) (NNS progenitors))))))
          (, ,) (IN whereas)
          (S
            (NP
              (NP (JJ other) (NN translocation) (NN fusion) (NNS proteins))
              (PRN (-LRB- -LRB-)
                (PP (FW e.g.) (, ,)
                  (NP (NN MOZ-TIF2)))
                (-RRB- -RRB-)))
            (VP (VBP do)
              (NP (NN -LSB-7)))
            (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN MLL)
        (PRN (-LRB- -LRB-)
          (NP (JJ mixed) (NN lineage) (NN leukaemia))
          (-RRB- -RRB-))
        (NN gene))
      (VP (VBZ has)
        (NP
          (NP
            (QP (JJR more) (IN than) (CD 30))
            (JJ known) (NN fusion) (NNS partners))
          (CD -LSB-9,10) (-RRB- -RSB-))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (JJ retroviral) (NN transduction) (NNS experiments))
        (PP (IN with)
          (NP (NN MLL-ENL) (NN fusion))))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (JJ multipotent) (JJ myeloid) (NNS progenitors))
              (CC and)
              (NP (VBN committed) (JJ myeloid) (NNS progenitors)))
            (VP (MD could)
              (VP (VB respond)
                (PP (TO to)
                  (NP (DT an) (NN MLL) (NN fusion) (NN protein))))
              (S
                (VP (TO to)
                  (VP (VB become)
                    (ADJP (JJ leukaemic)))))
              (, ,)
              (S
                (VP (VBG suggesting)
                  (NP
                    (NP (DT the) (NN existence))
                    (PP (IN of)
                      (NP (NN cancer) (NN stem) (NNS cells)))
                    (ADJP (JJ distinct)
                      (PP (IN from)
                        (NP
                          (NP (JJ multipotent) (NN stem) (NNS cells))
                          (PP (IN of)
                            (NP
                              (NP (DT the) (NN tissue))
                              (PP (IN of)
                                (NP (NN origin) (CD -LSB-11))))))))
                    (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (SBAR (IN While)
      (S
        (NP (DT some) (NNS translocations))
        (VP (VBP have)
          (NP (DT these) (JJ dual) (NNS properties)))))
    (, ,)
    (NP (NNS others))
    (ADVP (RB only))
    (VP (VBP function)
      (PP (IN in)
        (NP
          (NP (VBN committed) (NNS cells))
          (PP (JJ such) (IN as)
            (NP
              (NP (DT those) (NNS translocations))
              (VP (VBN mediated)
                (PP (IN by)
                  (NP
                    (NP (DT the) (JJ RAG-VDJ)
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (NN recombinase) (NN activating) (NN gene))
                          (CC and)
                          (NP
                            (NP
                              (NP (NN variable))
                              (, ,)
                              (NP (VBG joining))
                              (, ,)
                              (NP (NN diversity)))
                            (NNS regions)))
                        (-RRB- -RRB-))
                      (NN recombinase))
                    (PP (IN of)
                      (NP (DT the) (JJ lymphoid) (NN lineage) (NN -LSB-1) (-RRB- -RSB-)))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (NP
        (NP
          (ADJP (RB naturally) (VBG occurring))
          (NNS translocations))
        (, ,)
        (NP
          (NP
            (ADJP (JJ such)
              (PP (IN as)
                (NP
                  (NP (DT that))
                  (PP (IN of)
                    (NP (NN LMO2))))))
            (PRN (-LRB- -LRB-)
              (NP (NN LIM) (NN domain)
                (QP (RB only) (CD 2)))
              (-RRB- -RRB-)))
          (PP (IN in)
            (NP (NN T) (NN cell) (JJ acute) (NN leukaemia))))
        (, ,))
      (ADVP (RB only))
      (VP (VBP function)
        (PP (IN in)
          (NP (VBN committed) (NNS cells)))))
    (. .)))

(
  (S
    (S
      (NP (JJ Such) (NNS issues))
      (VP (VBP are) (RB not)
        (VP (VBN confined)
          (PP (TO to)
            (NP (JJ haematopoietic) (NNS malignancies))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN EWS-FUS) (NN family))
        (, ,)
        (VP
          (ADVP (RB typically))
          (VBN involved)
          (PP (IN in)
            (NP (NN sarcoma) (NN aetiology))))
        (, ,))
      (VP (VBZ exhibits)
        (NP
          (NP (NNS characteristics))
          (PP (IN of)
            (NP (NN tumour) (NNS initiators) (CD -LSB-12–15) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (NP
      (NP (DT The) (NN EWS) (NN gene))
      (, ,)
      (PP (IN at)
        (NP (NN Chromosome) (CD 22) (NN band) (CD q12)))
      (, ,))
    (VP (VBD was)
      (VP
        (VP
          (ADVP (RB first))
          (VBN identified)
          (PP (IN in)
            (NP (NN Ewing) (POS 's) (NN sarcoma)))
          (PP (IN by)
            (NP
              (NP (PRP$ its) (NN association))
              (PP (IN with)
                (NP
                  (NP (NN FLI1))
                  (CC and)
                  (NP (NN ATF1) (CD -LSB-16,17) (-RRB- -RSB-)))))))
        (CC and)
        (VP
          (ADVP (RB subsequently))
          (VBN found)
          (PP (IN in)
            (NP
              (NP (NNS subsets))
              (PP (IN of)
                (NP
                  (NP
                    (NP (NN Ewing) (POS 's) (NN sarcoma))
                    (PP (IN with)
                      (NP (CC either)
                        (NP (NN ERG))
                        (CC or)
                        (NP (NN ETV1)))))
                  (, ,)
                  (NP (CC and)
                    (NP
                      (NP (NN E1AF))
                      (CC and)
                      (NP (NN FEV) (CD -LSB-17–21)))
                    (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (DT the) (NN EWS) (NN gene))
    (VP (VBZ is)
      (VP (VBN involved)
        (PP
          (PP (IN in)
            (NP (JJ other) (NNS sarcomas)))
          (CC and)
          (PP (IN with)
            (NP
              (NP
                (ADJP (CC yet)
                  (ADJP (JJ different)))
                (NNS partners))
              (, ,)
              (PP (JJ such) (IN as)
                (NP
                  (NP (NN WT1))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Wilms) (NN tumour) (CD 1) (NN gene))
                    (-RRB- -RRB-))))))
          (PP (IN in)
            (NP
              (NP (JJ desmoplastic) (JJ small) (NN round) (NN cell) (NN sarcoma) (CD -LSB-22) (-RRB- -RSB-)
                (CC or)
                (NP (NNP CHN)))
              (PP (IN in)
                (NP (JJ myxoid) (NN chondrosarcoma) (NN -LSB-23)))))
          (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (JJ further) (NN ramification))
        (PP (IN of)
          (NP (DT this) (NN infidelity))))
      (VP (VBZ is)
        (SBAR (IN that)
          (S
            (S
              (NP
                (NP (DT the) (NN FUS) (NN gene))
                (, ,)
                (VP
                  (ADVP (RB first))
                  (VBN identified)
                  (PP (IN by)
                    (NP
                      (NP (PRP$ its) (NN fusion))
                      (PP (IN with)
                        (NP (DT the) (NN CHOP) (NN gene)))
                      (PP (IN in)
                        (NP
                          (NP
                            (NP (NN t) (-LRB- -LRB-) (CD 12) (: ;) (CD 16) (-RRB- -RRB-))
                            (PP (IN of)
                              (NP (JJ malignant) (JJ myxoid) (NN liposarcoma))))
                          (CC and)
                          (NP
                            (ADJP (JJ related)
                              (PP (TO to)
                                (NP (DT the) (NN EWS) (NN gene))))
                            (NN -LSB-24,25))))
                      (-RRB- -RSB-))))
                (, ,))
              (VP (VBZ has)
                (ADVP (RB also))
                (VP (VBN been)
                  (VP (VBN found)
                    (PP (IN in)
                      (NP
                        (NP (NN Ewing) (POS 's) (NN sarcoma))
                        (VP (VBN fused)
                          (PP (IN with)
                            (NP (DT the) (NN ERG) (NN gene))))))))))
            (, ,)
            (CC but)
            (S
              (ADVP (RB also))
              (NP (DT a) (JJ similar) (NN FUS-ERG) (NN fusion))
              (VP (VBZ has)
                (VP (VBN been)
                  (VP (VBN described)
                    (PP (IN in)
                      (NP (DT some) (JJ acute) (JJ myeloid) (NNS leukaemias)
                        (NP (CD -LSB-26–28) (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Finally))
      (, ,)
      (NP (DT the) (NN EWS) (NN gene))
      (VP (MD can)
        (ADVP (RB also))
        (VP (VB be)
          (VP (VBN involved)
            (PP (IN with)
              (NP (DT the) (NN CHOP) (NN gene)))
            (PP (IN by)
              (NP
                (NP (JJ chromosomal) (NN translocation))
                (PP (IN in)
                  (NP
                    (NP (JJ malignant) (JJ myxoid) (NN liposarcoma) (CD -LSB-29) (-RRB- -RSB-))
                    (, ,)
                    (ADJP (JJ analogous)
                      (PP (TO to)
                        (NP (NN FUS-CHOP))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ chromosomal) (NNS translocations))
        (PP (IN in)
          (NP
            (NP (NN Ewing) (POS 's))
            (CC and)
            (NP (JJ other) (NNS sarcomas)))))
      (VP (VBP are)
        (VP (VBN considered)
          (PP (IN as)
            (NP (JJ primary) (VBG initiating) (NNS events))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (NP (DT the) (NN EWS) (NNS fusions))
      (VP
        (VP (VBP function)
          (PP (IN in)
            (NP (DT the) (NN cancer) (NN precursor) (NN cell))))
        (CC and)
        (VP (VBP are)
          (VP (VBN required)
            (PP (IN throughout)
              (NP (NN tumour) (NN formation)))
            (PP (IN until)
              (NP
                (NP (DT the) (NN emergence))
                (PP (IN of)
                  (NP (DT the) (JJ overt) (NN cancer)))))
            (, ,)
            (SBAR (IN because)
              (S
                (NP (DT the) (JJ chromosomal) (NN translocation))
                (VP (VBZ is)
                  (ADJP (JJ present)
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN cancer))
                        (PP (IN at)
                          (NP
                            (NP (DT the) (NN time))
                            (PP (IN of)
                              (NP (NN presentation)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN fusion) (NN protein))
      (VP (MD may)
        (ADVP (RB therefore))
        (VP (VB be)
          (ADJP (JJ instructive))
          (PP (IN by)
            (S
              (VP (VBG imparting)
                (NP
                  (NP (DT a) (NN phenotype))
                  (PP (IN on)
                    (NP (DT the) (NN cell))))
                (PP (IN by)
                  (S
                    (VP (VBG affecting)
                      (NP
                        (NP (DT a) (JJ specific) (NN differentiation) (NN programme))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD must)
                              (VP (VB be)
                                (NP
                                  (NP (NN part))
                                  (PP (IN of)
                                    (NP
                                      (NP (DT the) (JJ genetic) (NN make-up))
                                      (PP (IN of)
                                        (NP (DT the) (NN cancer) (NN stem) (NN cell))))))
                                (, ,)
                                (SBAR (IN since)
                                  (S
                                    (NP (DT the) (JJ chromosomal) (NN translocation))
                                    (VP (VBZ is)
                                      (NP (DT an)
                                        (ADJP
                                          (ADJP (VBG initiating))
                                          (CC and)
                                          (ADJP (JJ persistent)))
                                        (NN feature)))))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ pre-existing) (NN chromosomal) (NN translocation))
      (VP (VBZ creates)
        (NP
          (NP (DT a) (JJ cellular) (NN environment))
          (VP (VBG allowing)
            (NP (JJ secondary) (NNS mutations))
            (S
              (VP (TO to)
                (VP (VB arise)
                  (PP (IN in)
                    (NP (NN progeny) (NNS cells))))))))
        (, ,)
        (S
          (VP (VBG resulting)
            (PP (IN in)
              (NP (JJ overt) (NN cancer)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Conditional) (NN mouse) (NNS models))
        (PP (IN of)
          (NP (DT the)
            (ADJP
              (ADJP (JJ EWS-))
              (CC and)
              (ADJP (JJ FUS-associated)))
            (JJ chromosomal) (NNS translocations))))
      (VP (MD should)
        (VP (VBP give)
          (NP
            (NP (NNS insights))
            (PP (IN into)
              (SBAR
                (WHADVP (WRB how))
                (S
                  (NP (DT these) (NNS fusions))
                  (VP (VBP influence)
                    (NP (DT the) (JJ malignant) (NN phenotype))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (VP (VBN analysed)
          (SBAR
            (SBAR (IN whether)
              (S
                (NP (NN EWS) (NNS fusions))
                (VP (VBP function)
                  (ADVP (RB only))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN domain))
                      (PP (IN of)
                        (NP (JJ mesenchymal) (NNS progenitors))))))))
            (CC and)
            (SBAR (IN whether)
              (S
                (NP (PRP they))
                (VP (VBP function)
                  (PP (IN in)
                    (NP (JJ other) (NN cell) (NNS lineages)))
                  (, ,)
                  (ADVP (RB specifically))
                  (PP (IN within)
                    (NP (VBN committed) (NNS cells)))
                  (, ,)
                  (SBAR (IN as)
                    (S
                      (VP (VBZ has)
                        (VP (VBN been)
                          (VP (VBN demonstrated)
                            (PP (IN for)
                              (NP (NN MLL) (NNS fusions) (CD -LSB-11) (-RRB- -RSB-)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (VP (VBN developed)
          (NP
            (NP (NN mouse) (NNS models))
            (VP (VBG mimicking)
              (NP (JJ chromosomal) (NNS translocations))
              (PP (IN by)
                (S
                  (VP (VBG employing)
                    (NP
                      (NP (JJ homologous) (NN recombination))
                      (PP (IN in)
                        (NP (JJ embryonic) (NN stem) (-LRB- -LRB-) (NN ES) (-RRB- -RRB-) (NNS cells))))
                    (S
                      (VP (TO to)
                        (VP (VB create)
                          (NP
                            (NP (JJ mutant) (NNS alleles))
                            (PP (IN in)
                              (NP (NNS mice)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS methods))
      (VP (VBD were)
        (NP (CC either)
          (NP
            (NP (DT the) (JJ knock-in) (NN model))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (VBD involved)
                  (S
                    (VP (VBG fusing)
                      (NP (DT the) (NN MLL) (NN gene) (NN partner) (NN AF9))
                      (PP (IN into)
                        (NP (DT the) (NN mouse) (NN Mll) (NN gene)))))
                  (, ,)
                  (S
                    (VP (VBG resulting)
                      (PP (IN in)
                        (NP (JJ acute) (JJ myeloid) (NNS leukaemias)))
                      (PP (IN in)
                        (NP (NNS mice) (CD -LSB-30,31) (-RRB- -RSB-))))))))
            (, ,))
          (CC or)
          (NP
            (NP (DT the) (NN translocator) (NN model))
            (CD -LSB-32,33) (-RRB- -RSB-)))
        (S
          (VP (TO to)
            (VP (VB give)
              (NP
                (ADJP (FW de) (FW novo))
                (NP (JJ chromosomal) (NNS translocations)))
              (, ,)
              (S
                (VP (VBG resulting)
                  (PP (IN in)
                    (NP (JJ cell-specific) (NNS leukaemias) (CD -LSB-34) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (NP (PRP We))
    (VP (VBP have)
      (VP (VBN applied)
        (NP
          (NP (DT a) (JJ new) (JJ conditional) (NN chromosomal) (NN translocation) (NN model))
          (-LRB- -LRB-)
          (VP (VBN designated)
            (NP (DT the) (JJ invertor) (NN model)))
          (-RRB- -RRB-) (CD -LSB-35) (-RRB- -RSB-))
        (PP (TO to)
          (NP (DT the) (NN EWS-ERG) (NN gene) (NN fusion)
            (S
              (VP (TO to)
                (VP (VB gain)
                  (NP
                    (NP (NNS insights))
                    (PP (IN into)
                      (NP
                        (NP (DT the) (JJ functional) (NN significance))
                        (PP (IN of)
                          (NP (DT the) (NN fusion) (NN protein)))
                        (PP (IN in)
                          (NP (NN tumourigenesis)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Invertor) (NNS mice))
      (VP (VBP are)
        (VP (VBN made)
          (PP (IN by)
            (S
              (VP (VBG knocking)
                (NP
                  (NP (DT a) (JJ floxed) (NN cDNA) (NN cassette))
                  (PP (IN into)
                    (NP
                      (NP (DT the) (NN intron))
                      (PP (IN of)
                        (NP (DT a) (NN target) (NN gene))))))
                (ADVP (RB downstream)
                  (PP (IN of)
                    (NP (DT the) (NN mouse) (NN exon))))
                (ADJP (JJ equivalent)
                  (PP (TO to)
                    (NP
                      (NP (DT that))
                      (VP
                        (ADVP (RB usually))
                        (VBN involved)
                        (PP (IN in)
                          (NP (JJ human) (JJ chromosomal) (NNS translocations)
                            (NP (CD -LSB-35) (-RRB- -RSB-))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ floxed) (NN cassette))
      (VP
        (VP (VBZ is)
          (VP (VBN introduced)
            (PP (IN into)
              (NP
                (NP (DT the) (NN intron))
                (PP (IN in)
                  (NP (DT a) (JJ reverse) (JJ transcriptional) (NN orientation)))))))
        (CC and)
        (VP (MD can)
          (VP (VB be)
            (VP (VBN inverted)
              (PP (IN by)
                (NP (NN Cre) (NN recombinase)))
              (S
                (VP (TO to)
                  (VP (VB create)
                    (NP
                      (NP (DT a) (NN transcription) (NN unit))
                      (ADJP (JJ capable)
                        (PP (IN of)
                          (S
                            (VP (VBG generating)
                              (NP
                                (NP (DT an) (JJ appropriate) (NN fusion) (NN mRNA))
                                (PRN (-LRB- -LRB-)
                                  (VP (VB see)
                                    (PP (IN below)
                                      (NP (CC and)
                                        (NN Figure) (NN 1A))))
                                  (-RRB- -RRB-))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (VP (VBN sought)
          (S
            (VP
              (VP (TO to)
                (VP (VB determine)
                  (SBAR (IN whether)
                    (S
                      (NP (DT an) (NN Ews-ERG) (NN fusion))
                      (VP (MD can)
                        (VP (VB be)
                          (ADJP (JJ oncogenic)
                            (PP (IN in)
                              (NP
                                (NP (DT a) (NN cell) (NN type))
                                (VP (RB not)
                                  (ADVP (RB generally))
                                  (VBN associated)
                                  (PP (IN with)
                                    (NP (JJ human) (NNS tumours)))
                                  (PRN (-LRB- -LRB-)
                                    (ADVP (RB specifically))
                                    (PP (IN in)
                                      (NP (JJ lymphoid) (NNS cells)))
                                    (-RRB- -RRB-))))))))))))
              (CC and)
              (ADVP (RB also))
              (VP (TO to)
                (VP (VB determine)
                  (SBAR (IN whether)
                    (S
                      (NP (NN Ews-ERG) (NN fusion))
                      (VP (MD can)
                        (VP (VB initiate)
                          (NP (NN leukaemia))
                          (PP (IN from)
                            (NP (VBN committed) (NNS cells))))))))))))))
    (. .)))

(
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (JJ clonal) (NN T) (NN cell) (NN lymphoma))
          (VP (VBP arose)
            (PP (IN in)
              (NP (DT the) (NN invertor) (NN model)))
            (SBAR
              (WHADVP (WRB when))
              (S
                (NP (NN Cre) (NN expression))
                (VP (VBD was)
                  (VP (VBN controlled)
                    (PP (IN by)
                      (NP (DT the) (JJ lymphocyte-specific) (NN Rag1) (NN gene)))))))
            (, ,)
            (S
              (VP (VBG showing)
                (SBAR (IN that)
                  (S
                    (NP (NN Ews-ERG))
                    (VP (VBZ is)
                      (ADJP (JJ leukaemogenic)
                        (PP (IN in)
                          (NP (JJ lymphoid) (NNS cells)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (NNS results))
      (VP
        (VP (VBP show)
          (SBAR (IN that)
            (S
              (NP (NN Ews-ERG))
              (VP (MD can)
                (VP (VB function)
                  (PP (IN as)
                    (NP (DT an) (NN oncogene)))
                  (PP (IN in)
                    (NP
                      (NP (VBN committed) (NNS cells))
                      (PP (IN of)
                        (NP (NNS mice))))))))))
        (CC and)
        (VP (VBP suggest)
          (SBAR (IN that)
            (S
              (NP (NN EWS-ERG))
              (VP (VBZ is)
                (ADJP (JJ able)
                  (S
                    (VP (TO to)
                      (VP (VB contribute)
                        (PP (TO to)
                          (NP
                            (NP (NN neoplasia))
                            (PP (IN in)
                              (NP
                                (NP (DT a) (NN variety))
                                (PP (IN of)
                                  (NP (JJ cellular) (NNS contexts)))))))
                        (ADVP (FW in) (FW vivo))))))))))))
    (. .)))

(
  (S
    (NP (NNS Results))))

(
  (S
    (S
      (NP
        (NP (DT The) (NN use))
        (PP (IN of)
          (NP (JJ homologous) (NN recombination)))
        (S
          (VP (TO to)
            (VP (VB generate)
              (NP (NN oncogene) (NNS fusions))))))
      (VP (VBD was)
        (VP (VBN established)
          (PP (IN with)
            (NP
              (NP (DT the) (NN creation))
              (PP (IN of)
                (NP (DT the) (NN Mll-AF9) (NN mouse) (NN model) (CD -LSB-30)))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (NP (PRP We))
    (VP (VBD attempted)
      (NP
        (NP (DT a) (JJ similar) (NN approach))
        (S
          (VP (TO to)
            (VP (VB make)
              (NP
                (NP (NN Ews) (NNS fusions))
                (PP (IN of)
                  (NP
                    (NP (DT the) (NN type))
                    (VP (VBN found)
                      (PP (IN in)
                        (NP
                          (NP (JJ specific) (JJ human) (NNS sarcomas))
                          (CC and)
                          (NP
                            (NP (NNS leukaemias))
                            (PRN (-LRB- -LRB-)
                              (S
                                (NP (NN Figure) (NN S1))
                                (VP (VBZ shows)
                                  (NP
                                    (NP (NNS sequences))
                                    (PP (IN of)
                                      (NP
                                        (NP
                                          (NP (NN Chop))
                                          (, ,)
                                          (NP (NN ATF1))
                                          (, ,)
                                          (CC and)
                                          (NP (NN Fli1)))
                                        (PP
                                          (ADVP (RB together))
                                          (IN with)
                                          (NP
                                            (NP (NN AF9) (NNS sequences))
                                            (VP (VBN used)
                                              (PP (IN for)
                                                (NP (DT the) (JJ knock-in) (NN targeting) (NNS clones)))))))))))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

(
  (S
    (SBAR (IN While)
      (S
        (NP (PRP we))
        (VP (VBD were)
          (ADJP (JJ able)
            (S
              (VP (TO to)
                (VP (VB obtain)
                  (NP (JJ homologous) (NN recombination) (NN knock-in) (NNS clones))))))
          (PP (CC either)
            (PP (IN with)
              (NP
                (NP (DT a) (NN vector))
                (VP (VBG carrying)
                  (NP (RB only) (DT a) (NN transfer) (NN cassette)))))
            (CC or)
            (PP (IN with)
              (NP (DT the) (NN Ews-AF9) (NN control) (NN fusion)))))))
    (, ,)
    (NP (DT no) (NNS clones))
    (VP (VBD were)
      (VP (VBN obtained)
        (PP (IN with)
          (NP
            (NP (DT any))
            (PP (IN of)
              (NP
                (NP (DT the) (NN Ews) (NNS fusions))
                (ADJP (JJ equivalent)
                  (PP (TO to)
                    (NP
                      (NP (DT those))
                      (VP
                        (ADVP (RB naturally))
                        (VBN found)
                        (PP (IN in)
                          (NP
                            (NP (JJ human) (NNS cancers))
                            (PRN (-LRB- -LRB-)
                              (NP (NN Table) (NN S1))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP (NNS chimaeras))
      (VP (MD could)
        (VP (VB be)
          (VP (VBN made)
            (PP (IN with)
              (NP
                (NP (DT the) (NN Ews) (NN cassette))
                (CC and)
                (NP
                  (NP (DT the) (NN Ews-AF9) (NN knock-in))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Table) (NN S1))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD concluded)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN Ews) (NNS fusions))
              (PP (IN of)
                (NP
                  (NP (DT the) (NN type))
                  (VP
                    (ADVP (RB naturally))
                    (VBN associated)
                    (PP (IN with)
                      (NP (JJ human) (NNS cancers)))))))
            (VP (MD could)
              (VP (VB be)
                (ADJP (JJ lethal))
                (PP (IN in)
                  (NP (NN ES) (NNS cells)))
                (, ,)
                (S
                  (VP (VBG obviating)
                    (NP
                      (NP (DT the) (NN generation))
                      (PP (IN of)
                        (NP (VBN targeted) (NNS cells))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (ADVP (RB recently))
        (VP (VBN developed)
          (NP
            (NP (DT a) (JJ new) (JJ conditional) (NN knock-in) (NN method))
            (VP (VBN based)
              (PP (IN on)
                (NP
                  (NP (NN inversion))
                  (PP (IN of)
                    (NP (DT a) (JJ loxP-flanked) (NN cDNA) (NN cassette)))))))
          (PP (IN by)
            (NP (NN Cre) (NN recombinase) (CD -LSB-35) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (JJ Ews-ERG) (NN invertor) (NN model))
      (VP (VBZ is)
        (ADVP (RB diagrammatically))
        (VP (VBN shown)
          (PP (IN in)
            (NP (NN Figure) (NN 1A))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN outline)))
      (, ,)
      (NP
        (NP (JJ homologous) (NN recombination))
        (PP (IN in)
          (NP (NN mouse) (NN ES) (NNS cells))))
      (VP (VBD was)
        (VP (VBN used)
          (S
            (VP (TO to)
              (VP (VB introduce)
                (NP (DT a) (JJ floxed) (NN ERG) (NN cDNA) (NN cassette))
                (ADVP (RB downstream)
                  (PP (IN of)
                    (NP
                      (NP (NN Ews) (NN exon) (CD 7.))
                      (S
                        (NP (DT The) (NN cassette))
                        (VP (VBD comprised)
                          (NP
                            (NP (DT a) (JJ short) (JJ intronic) (NN sequence))
                            (, ,)
                            (NP (DT an) (NN acceptor) (NN splice) (NN site))
                            (, ,)
                            (NP (NN ERG) (NN cDNA))
                            (, ,)
                            (NP (DT a) (NN polyA) (NN site))
                            (, ,)
                            (CC and)
                            (NP
                              (NP (DT a) (NN neomycin) (NN gene))
                              (-LRB- -LRB-)
                              (VP (TO to)
                                (VP (VB select)
                                  (NP (JJ homologous) (JJ recombinant) (NN ES) (NNS cells))))
                              (-RRB- -RRB-) (, ,)
                              (VP (VBN placed)
                                (PP (IN in)
                                  (NP
                                    (NP (DT the) (JJ opposite) (NN transcription) (NN orientation))
                                    (PP (TO to)
                                      (NP (DT the) (NN Ews) (NN gene)))))))))))))))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Expression))
      (PP (IN of)
        (NP (NN Cre) (NN recombinase))))
    (VP (VBZ inverts)
      (NP (DT the) (NN cassette))
      (, ,)
      (S
        (VP (VBG bringing)
          (NP (DT the) (NN acceptor) (NN splice) (NN site))
          (PP (IN into)
            (NP
              (NP (DT the) (JJ correct) (NN orientation))
              (PP (IN with)
                (NP (DT the)
                  (NP (NN Ews) (NN exon) (CD 7))
                  (NN donor) (NN splice) (NN site)))))
          (, ,)
          (S
            (VP (TO to)
              (VP (VB allow)
                (NP
                  (NP (JJ post-transcriptional) (NN production))
                  (PP (IN of)
                    (NP (NN Ews-ERG) (NN fusion) (NN mRNA)))))))
          (PRN (-LRB- -LRB-)
            (S
              (NP (NN Figure) (NN 1B))
              (VP (VBZ shows)
                (NP
                  (NP (DT the) (JJ post-inversion) (JJ genomic) (NN sequence))
                  (PP (IN at)
                    (NP
                      (NP (DT the) (NN junction))
                      (PP (IN of)
                        (NP
                          (NP (NN Ews))
                          (CC and)
                          (NP (NN ERG)))))))))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (S
        (NP (VBN Targeted) (NN ES) (NNS cells))
        (VP (VBD were)
          (VP (VBN injected)
            (PP (IN into)
              (NP (NNS blastocysts))))))
      (, ,)
      (CC and)
      (S
        (NP (DT these))
        (VP (VBD yielded)
          (NP
            (NP (JJ normal) (NNS numbers))
            (PP (IN of)
              (NP (NNS chimaeras)))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (VBD gave)
                  (NP (NN rise))
                  (PP (TO to)
                    (NP
                      (NP (JJ heterozygous) (NNS carriers))
                      (PP (IN of)
                        (NP
                          (NP (DT the) (JJ Ews-ERG) (NN invertor) (NN allele))
                          (PRN (-LRB- -LRB-)
                            (NP (NN invertor) (NNS mice))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT these) (JJ invertor) (NNS mice)))
      (, ,)
      (NP (NN Ews-ERG) (NN protein))
      (VP
        (VP (MD can)
          (ADVP (RB only))
          (VP (VB be)
            (VP (VBN made)
              (PP (IN after)
                (NP (JJ Cre-mediated) (NN inversion))))))
        (CC and)
        (ADVP (RB thus))
        (VP (MD can)
          (VP (VB be)
            (ADJP (RB cell-specifically) (JJ dependent)
              (PP (IN on)
                (NP (NN Cre) (NN expression))))))))
    (. .)))

(
  (S
    (NP (PRP We))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN ability))
        (PP (IN of)
          (NP (NN Ews-ERG) (NN fusion) (NN protein)))
        (S
          (VP (TO to)
            (VP (VB contribute)
              (PP (TO to)
                (NP (NN leukaemogenesis)))
              (PP (IN by)
                (S
                  (VP (VBG causing)
                    (NP
                      (NP (DT the) (NN inversion))
                      (PP (IN of)
                        (NP (DT the) (JJ ERG-containing) (NN cassette)))
                      (PP (IN in)
                        (NP (JJ lymphoid) (NNS cells))))
                    (S
                      (VP (VBG using)
                        (NP
                          (NP (NN Rag1-Cre) (NN knock-in) (NNS mice))
                          (CD -LSB-36) (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (PP (RB Out) (IN of)
      (NP
        (NP (DT the) (NN cohort))
        (PP (IN of)
          (NP
            (NP (CD 29) (NNS mice))
            (VP (VBG carrying)
              (NP (CC both)
                (NP (NN Ews-ERG))
                (CC and)
                (NP (NN Rag1-Cre) (NNS genes))))))))
    (, ,)
    (NP
      (NP (CD 25) (NNS mice))
      (PRN (-LRB- -LRB-)
        (NP (CD 86) (NN %))
        (-RRB- -RRB-)))
    (VP (VBD developed)
      (NP
        (NP (NN leukaemia))
        (VP (VBN associated)
          (PP (IN with)
            (NP (NN thymoma)))))
      (PP (IN within)
        (NP (CD 500) (NN d)))
      (, ,)
      (SBAR (IN whereas)
        (S
          (NP
            (NP (DT the) (JJ Ews-ERG-only) (NN cohort))
            (PRN (-LRB- -LRB-)
              (NP (CD 20) (NNS mice))
              (-RRB- -RRB-)))
          (VP (VBD did) (RB not)
            (VP (VB display)
              (NP (NN neoplasia))
              (PRN (-LRB- -LRB-)
                (NP (NN Figure) (CD 2))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Blood) (NNS smears))
        (PP (IN at)
          (NP
            (NP (DT the) (NN time))
            (PP (IN of)
              (NP (NN sacrifice)))
            (PP (IN of)
              (NP (NN Ews-ERG) (: ;) (NN Rag1-Cre) (NNS mice))))))
      (ADVP (RB typically))
      (VP (VBD showed)
        (NP
          (NP (JJ elevated) (NNS numbers))
          (PP (IN of)
            (NP (JJ large) (NNS leukocytes))))
        (, ,)
        (PP (IN with)
          (NP
            (NP (JJ lymphoid) (NN morphology))
            (PP (IN of)
              (NP
                (NP (JJ different) (NNS maturities))
                (, ,)
                (PP (VBG including)
                  (NP
                    (NP (NNS lymphoblasts))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Figure) (CD 2))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN addition)))
      (, ,)
      (NP (NN bone) (NN marrow) (NNS sections))
      (VP (VBD showed)
        (NP
          (NP (JJ high) (NNS levels))
          (PP (IN of)
            (NP
              (NP (JJ infiltrating) (NNS lymphoblasts))
              (PRN (-LRB- -LRB-)
                (NP (NN Figure) (CD 2))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (DT The) (JJ diseased) (NNS mice))
          (NP (DT all)))
        (VP (VBD had)
          (NP
            (NP (JJ large) (NNS thymomas))
            (, ,)
            (VP
              (ADVP (RB usually))
              (VBN associated)
              (PP (IN with)
                (NP
                  (NP
                    (NP (NN splenomegaly))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Table) (CD 1))
                      (-RRB- -RRB-)))
                  (CC and)
                  (NP (NN lymphadenopathy))))))))
      (, ,)
      (CC and)
      (S
        (NP
          (NP (DT the) (NN histology))
          (PP (IN of)
            (NP (NNS spleens))))
        (VP (VBD showed)
          (NP
            (NP
              (NP (DT either) (JJ complete) (NN loss))
              (PP (IN of)
                (NP
                  (NP (JJ normal) (NN architecture))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NN loss))
                      (PP (IN of)
                        (NP (VBN demarcated) (JJ white)
                          (CC and)
                          (JJ red) (NN pulp))))
                    (-RRB- -RRB-)))))
            (, ,)
            (NP (JJ partial) (NN loss))
            (, ,)
            (CC or)
            (NP
              (NP (JJ normal) (NN architecture))
              (PRN (-LRB- -LRB-)
                (NP (NN Figure) (NN S2))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Similarly))
      (, ,)
      (NP
        (NP (DT the) (NN level))
        (PP (IN of)
          (NP
            (NP (NN infiltration))
            (PP (IN of)
              (NP (JJ leukaemic) (NNS lymphocytes)))
            (PP (IN into)
              (NP
                (NP (NN liver))
                (CC and)
                (NP (NN kidney)))))))
      (VP (VBD varied) (, ,)
        (PP (IN with)
          (NP
            (NP (DT some))
            (VP (VBG having)
              (NP
                (NP
                  (NP (JJ large) (NNS amounts))
                  (PP (IN of)
                    (NP (JJ perivascular) (NNS deposits))))
                (CC and)
                (NP (NNS others))
                (NP (JJ marginal) (NNS levels))))))))
    (. .)))

(
  (S
    (S
      (NP (DT All) (NNS mice))
      (VP (VBD had)
        (NP (NN thymomas))
        (PP (IN with)
          (NP
            (NP (JJ homogeneous) (NN presence))
            (PP (IN of)
              (NP (JJ large) (JJ leukaemic) (NNS cells)))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS characteristics))
      (, ,)
      (PP
        (ADVP (RB together))
        (IN with)
        (NP
          (NP (NN evidence))
          (PP (IN of)
            (NP
              (NP (JJ clonal) (NN Tcrb) (NN gene) (NNS rearrangements))
              (CC and)
              (NP
                (NP (NN expression))
                (PP (IN of)
                  (NP
                    (NP (JJ TCR-associated) (NN CD8))
                    (CC and)
                    (NP
                      (NP (NN CD4))
                      (PRN (-LRB- -LRB-)
                        (VP (VB see)
                          (PP (IN below)))
                        (-RRB- -RRB-))))))))))
      (, ,)
      (VP (VBP permit)
        (NP
          (NP (NN diagnosis))
          (PP (IN of)
            (NP (JJ large) (NN cell) (JJ anaplastic) (NN T) (NN cell) (NN lymphoma))))
        (PP (VBG according)
          (PP (TO to)
            (NP
              (NP (DT the) (JJ Bethesda) (NNS proposals))
              (PP (IN for)
                (NP
                  (NP (JJ lymphoid) (NNS tumours))
                  (PP (IN in)
                    (NP (NNS mice) (CD -LSB-37) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (NP (DT The) (NN Ews-ERG) (NN fusion))
    (VP (VBZ appears)
      (ADJP (JJ crucial)
        (PP (IN for)
          (NP
            (NP (NNS malignancies))
            (PP (IN in)
              (NP (DT the) (JJ invertor) (NNS mice))))))
      (, ,)
      (SBAR (IN as)
        (S
          (NP (NN disease))
          (ADVP (RB only))
          (VP (VBP arose)
            (PP (IN in)
              (NP
                (NP (NNS mice))
                (PP (IN with)
                  (NP (CC both)
                    (NP
                      (NP (DT the)
                        (NP
                          (NP (NN Ews-ERG))
                          (CC and)
                          (NP (NN Rag1-Cre)))
                        (NNS genes))
                      (PRN (-LRB- -LRB-)
                        (NP (NN Figure) (CD 2))
                        (-RRB- -RRB-)))
                    (CC and)
                    (NP
                      (NP (VBN comprised) (JJ clonal) (NNS tumours))
                      (PRN (-LRB- -LRB-)
                        (NP (NN Figure) (CD 3))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN presence))
        (PP (IN of)
          (NP (NN Ews-ERG) (NN mRNA))))
      (VP (VBD was)
        (VP (VBN confirmed)
          (PP (IN in)
            (NP
              (NP (NNS spleens))
              (PP (IN of)
                (NP (DT these) (NNS mice)))))
          (, ,)
          (S
            (ADJP (JJ identical)
              (PP (IN with)
                (NP
                  (NP (DT that))
                  (PP (IN in)
                    (NP
                      (NP (NN Ews-ERG) (NN ES) (NNS cells))
                      (VP (VBN transfected)
                        (PP (IN with)
                          (NP
                            (NP (NN Cre) (NN expression) (NNS plasmids))
                            (PRN (-LRB- -LRB-)
                              (S
                                (VP (VB see)
                                  (NP (NN Figure) (NN S1))))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN addition)))
      (, ,)
      (NP
        (NP
          (NP (DT the) (JJ steady) (NN state))
          (NN orientation))
        (PP (IN of)
          (NP (DT the) (JJ loxP-flanked) (NN ERG) (NN cassette))))
      (VP (VBD was)
        (VP (VBN studied)
          (S
            (VP (VBG using)
              (NP (NN filter) (NN hybridisation)))))))
    (CC and)
    (S
      (NP (PRP we))
      (VP (VBD found)
        (SBAR (IN that)
          (S
            (NP (DT the) (NN ERG) (NN sequence))
            (VP (VBD had)
              (VP (VBN become)
                (VP (VBN inverted)
                  (PP (IN into)
                    (NP
                      (NP (DT the) (NN 5′))
                      (PP (TO to)
                        (NP (NN 3′) (NN orientation)))
                      (PP (IN with)
                        (NP
                          (NP (NN respect))
                          (PP (TO to)
                            (NP (DT the) (NN Ews) (NN gene)))))))
                  (PP (IN in)
                    (NP
                      (NP (DT each) (NN case))
                      (PP (IN of)
                        (NP
                          (NP (NN thymoma))
                          (PRN (-LRB- -LRB-)
                            (NP
                              (NP (NN Figure) (NN 3A))
                              (: ;)
                              (NP (NN Table) (CD 1)))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ other) (NNS tissues))
        (VP (VBN examined)))
      (VP (VBP have)
        (NP
          (NP (JJ little) (NN evidence))
          (PP (IN of)
            (NP (DT an) (JJ inverted) (NN band))))))
    (. .)))

(
  (S
    (ADVP (RB Finally))
    (, ,)
    (NP
      (NP (DT the) (NN presence))
      (PP (IN of)
        (NP (DT the) (NN Ews-ERG) (NN fusion) (NN protein))))
    (VP (VBD was)
      (VP (VBN shown)
        (PP (IN by)
          (NP
            (NP (NN Western) (NN blotting))
            (PP (IN of)
              (NP (NN thymoma) (NNS proteins)))))
        (S
          (VP (VBG using)
            (NP
              (NP (NNS antibodies))
              (VP (VBG binding)
                (PP (TO to)
                  (NP (CC either)
                    (NP (NN Ews))
                    (CC or)
                    (NP (NN ERG)))))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBD detected)
                    (ADVP (RB respectively))
                    (NP
                      (NP (DT the) (JJ normal) (NN mouse) (NN Ews)
                        (CC or)
                        (NN Erg) (NNS proteins))
                      (CC and)
                      (NP
                        (NP (DT the) (NN Ews-ERG) (NN fusion) (NN molecule))
                        (PP (IN in)
                          (NP (NN thymoma) (NN T) (NNS cells)))
                        (PP (IN of)
                          (NP (DT an) (NN Ews-ERG)))))))))))))
    (: ;)
    (NP
      (NP (NN Rag1-Cre) (NN mouse))
      (PRN (-LRB- -LRB-)
        (NP (NN Figure) (NN 3D))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (S
      (S
        (S
          (NP
            (NP (NNS Studies))
            (PP (IN of)
              (NP (NN progenitor) (NN gene) (NN expression))))
          (VP (VBP have)
            (VP (VBN indicated)
              (NP
                (NP (DT the) (JJ promiscuous) (NN expression))
                (PP (IN of)
                  (NP (JJ lymphoid) (NNS markers)))))))
        (VP (VBZ precedes)
          (NP (NN lineage) (NN commitment) (CD -LSB-38) (-RRB- -RSB-))))
      (CC and)
      (S
        (ADVP (RB thus))
        (, ,)
        (NP (DT the) (NN Rag1-Cre) (NN allele))
        (VP (MD might)
          (VP (VB be)
            (VP (VBG expressing)
              (PP (IN in)
                (NP
                  (NP (NNS cells))
                  (VP (VBN destined)
                    (S
                      (VP (TO to)
                        (VP (VB become)
                          (ADJP (JJ non-lymphoid)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN Rag1-Cre) (NN knock-in) (NN allele))
      (VP (VBD was)
        (ADVP (RB previously))
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB be)
                (ADJP (JJ specific)
                  (PP (IN for)
                    (NP
                      (NP (JJ lymphoid) (NNS cells))
                      (VP (VBG using)
                        (NP
                          (NP (DT a) (NN reporter) (NN assay))
                          (ADJP (JJ dependent)
                            (PP (IN on)
                              (NP
                                (NP (JJ Cre-mediated) (NN deletion))
                                (PP (IN of)
                                  (NP
                                    (NP (DT a) (JJ loxP-flanked) (-LRB- -LRB-) (JJ floxed) (-RRB- -RRB-) (NN segment))
                                    (PP (IN of)
                                      (NP (DT the) (NN Lmo2) (NN gene) (NN -LSB-36))))))))
                          (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (VP (VBN sustained)
          (NP (DT these) (NNS observations))
          (S
            (VP (VBG using)
              (NP
                (NP (DT an) (JJ additional) (NN reporter) (NN assay))
                (, ,)
                (ADVP (RB namely))
                (NP (DT the) (NN ROSA-loxSTOP-lacZ) (-LRB- -LRB-) (NN ROSA26-R) (-RRB- -RRB-) (NN allele) (NN -LSB-39) (-RRB- -RSB-)
                  (SBAR
                    (WHADVP (WRB where))
                    (S
                      (NP (NN β-galactosidase) (-LRB- -LRB-) (NN βgal) (-RRB- -RRB-) (NN expression))
                      (VP (VBZ is)
                        (VP (VBN activated)
                          (PP (IN by)
                            (NP
                              (NP (NN deletion))
                              (PP (IN of)
                                (NP (DT a) (NN loxP-pA) (NN site))))))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (JJ Haematopoietic) (NNS populations))
          (PP (IN from)
            (NP
              (NP (NNS mice))
              (VP (VBG carrying)
                (NP (DT both)
                  (NP
                    (NP (NN Rag1-Cre))
                    (CC and)
                    (NP (NN ROSA26-R)))
                  (NNS alleles))))))
        (VP (VBD were)
          (VP (VBN stained)
            (PP (IN with)
              (NP
                (NP (JJ fluorescent) (NNS antibodies))
                (VP (VBG binding)
                  (PP (TO to)
                    (NP (JJ various) (NN surface) (NNS markers)))))))))
      (, ,)
      (CC and)
      (S
        (NP (NN flow) (NN cytometry))
        (VP (VBD was)
          (VP (VBN carried)
            (PRT (RP out))
            (PP (IN for)
              (NP
                (NP (NN co-detection))
                (PP (IN of)
                  (NP
                    (NP
                      (ADJP
                        (ADJP (JJ antibody-))
                        (CC and)
                        (ADJP (JJ βgal-derived)))
                      (NN fluorescence))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Figure) (NN S3))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (NP (JJ βgal) (NN signal))
    (VP
      (VP (VBD was)
        (VP (VBN found)
          (PP (IN in)
            (NP
              (NP
                (NP (NN thymus))
                (CC and)
                (NP (NN spleen)))
              (PRN (-LRB- -LRB-)
                (NP
                  (QP (RB almost) (PDT all))
                  (NNS cells))
                (-RRB- -RRB-))))
          (, ,)
          (CC and)
          (PP (IN in)
            (NP
              (NP (NN bone) (NN marrow))
              (, ,)
              (NP
                (NP (DT a) (NN population))
                (PP (IN of)
                  (NP (NN βgal+) (NNS cells))))))
          (VP (VB exist))))
      (CC but)
      (VP (VBD did) (RB not)
        (VP (VB co-express)
          (PP (IN with)
            (NP
              (NP (NN CD34))
              (, ,)
              (NP (NN Sca1))
              (, ,)
              (NP (NN Ckit))
              (, ,)
              (CC or)
              (NP
                (NP (CD Ter119))
                (PRN (-LRB- -LRB-)
                  (CC or)
                  (NP
                    (NP (NN Mac1))
                    (, ,)
                    (VP (RB not) (VBN shown)))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT This) (NN means))
        (PP (IN that)
          (NP (DT the) (NN Rag1-Cre))))
      (VP (VBZ is)
        (ADJP (JJ restricted)
          (PP (TO to)
            (NP (JJ lymphoid) (NNS cells))))
        (, ,)
        (SBAR (IN as)
          (S
            (ADVP (RB previously))
            (VP (VBN shown)
              (NP (CD -LSB-36) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT The) (NN Rag1-Cre) (NN gene))
        (VP (VBZ is)
          (VP (VBN expressed)
            (PP (IN in)
              (NP (DT both) (NN B)
                (CC and)
                (NN T) (NNS cells))))))
      (, ,)
      (CC but)
      (S
        (NP (JJ only) (NN T) (NN cell) (NNS tumours))
        (VP (VBP have)
          (VP (VBN arisen)
            (PP (IN in)
              (NP (DT the) (NN Ews-ERG) (: ;) (NN Rag1-Cre) (NN invertor) (NN line)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ possible) (NN inversion))
        (PP (IN of)
          (NP (DT the) (NN Ews-ERG) (NN gene)))
        (PP (IN in)
          (NP (NN B) (NNS cells))))
      (VP (VBD was)
        (VP (VBN investigated)
          (S
            (VP (VBG using)
              (NP
                (NP (NN RT-PCR) (NN analysis))
                (PP (IN of)
                  (NP
                    (NP (VBN expressed) (NN Ews-ERG) (NN fusion) (NN mRNA))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Figure) (CD 4))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NN RNA))
        (VP (VBD was)
          (VP (VBN prepared)
            (PP
              (PP (IN from)
                (NP
                  (NP (JJ whole) (NN spleen))
                  (CC or)
                  (NP (NN thymus))))
              (CC or)
              (PP (IN from)
                (NP
                  (NP
                    (NP (JJ flow-sorted) (NN B220+) (NN spleen) (NNS cells))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 3,400) (NNS cells))
                      (-RRB- -RRB-)))
                  (CC or)
                  (NP
                    (NP (NN Thy1.2+) (NN spleen) (NNS cells))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 6,400) (NNS cells))
                      (-RRB- -RRB-)))))))))
      (CC and)
      (S
        (NP (NN RT-PCR))
        (VP (VBN performed))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Pax5))
        (CC and)
        (NP (NN CD3))
        (NP (NNS primers) (CD -LSB-38) (-RRB- -RSB-)))
      (VP (VBD were)
        (VP (VBN used)
          (PP (IN for)
            (NP
              (NP (JJ specific) (NN detection))
              (PP (IN of)
                (NP
                  (NP
                    (NP (NN B) (NN cell))
                    (CC and)
                    (NP (NN T) (NN cell)))
                  (NNS transcripts)))))
          (, ,)
          (ADVP (RB respectively)))))
    (. .)))

(
  (S
    (NP (NN Pax5) (NNS transcripts))
    (VP
      (VP (VBD were)
        (VP (VBN detected)
          (PP (IN in)
            (NP
              (NP (NN cDNA))
              (VP (VBN made)
                (PP (IN from)
                  (NP
                    (NP
                      (NP (NN spleen))
                      (CC and)
                      (NP (NN B220+)))
                    (VBN sorted) (NNS cells))))))))
      (, ,)
      (CC and)
      (VP
        (NP (NN CD3))
        (PP (IN in)
          (NP (DT the)
            (NP
              (NP (NN spleen))
              (, ,)
              (NP (NN thymus))
              (CC and)
              (NP (NN thy1.2+)))))))))

(
  (S
    (S
      (NP
        (NP (VBN sorted) (NNS cells))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NN Figure) (NN 4A))
            (CC and)
            (NP (NN 4B)))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT No) (NN evidence))
        (PP (IN of)
          (NP (NN CD3) (NN expression))))
      (VP (VBD was)
        (VP (VBN found)
          (PP
            (PP (IN in)
              (NP (DT the) (VBN sorted) (NN B220+) (NNS cells)))
            (, ,)
            (CC or)
            (PP (IN of)
              (NP (NN Pax5))))
          (PP (IN in)
            (NP (DT the) (VBN sorted) (NN Thy1.2+) (NNS cells))))
        (, ,)
        (S
          (VP (VBG showing)
            (SBAR (IN that)
              (S
                (NP (DT the) (VBN sorted) (NNS cells))
                (VP (VBD were)
                  (ADJP (RB practically) (JJ free)
                    (PP (IN of)
                      (S
                        (VP (VBG contaminating)
                          (NP (NN T)
                            (CC or)
                            (NN B) (NNS cells))
                          (, ,)
                          (ADVP (RB respectively)))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN presence))
        (PP (IN of)
          (NP (NN Ews-ERG) (NN fusion) (NN RNA))))
      (VP (VBD was)
        (VP (VBN analysed)
          (PP (IN with)
            (NP (NN RT-PCR) (NNS primers)))
          (, ,)
          (S
            (VP (VBG yielding)
              (NP
                (NP (DT a) (NN product))
                (VP (VBG spanning)
                  (NP
                    (NP (DT the) (NN fusion) (NN junction))
                    (SBAR
                      (WHNP (WDT that))
                      (S
                        (VP (VBD was)
                          (VP (VBN detected)
                            (PP (IN with)
                              (NP (DT an) (JJ internal) (NN junction) (NN probe)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Ews-ERG) (NN RT-PCR) (NN product))
      (VP (VBD was)
        (VP (VBN detected)
          (PP
            (PP (IN in)
              (NP
                (NP (DT the) (JJ unfractionated) (NN spleen))
                (CC and)
                (NP (NN thymus))
                (NP (NNS sources))))
            (, ,)
            (CONJP (RB as) (RB well) (IN as))
            (PP (IN in)
              (NP (DT the) (VBN purified) (, ,)
                (NP (VBN sorted) (NN B220+)
                  (CC and)
                  (NN Thy1.2+) (NNS cells))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Therefore))
      (, ,)
      (NP
        (NP (JJ Cre-mediated) (NN inversion))
        (PP (IN of)
          (NP (DT the) (NN Ews-ERG) (NN gene))))
      (VP (VBZ occurs)
        (PP (IN in)
          (NP
            (NP (CC both)
              (NP (NN T))
              (CC and)
              (NP (NN B)))
            (NNS cells)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN presence))
        (PP (IN of)
          (NP (NN thymomas)))
        (PP (IN in)
          (NP (DT all) (JJ afflicted) (NN Ews-ERG) (: ;) (NN Rag1-Cre) (NNS mice))))
      (VP (VBD suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (JJ haematological) (NN malignancy))
              (PP (IN in)
                (NP (DT these) (NNS mice))))
            (VP (VBD comprised)
              (NP (NN T) (NNS cells)))))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (VBD was)
        (VP (VBN confirmed)
          (PP
            (PP (IN by)
              (NP
                (NP (NN FACS) (NN analysis))
                (PP (IN of)
                  (NP (NN T) (NN cell) (NN surface) (NNS markers)))))
            (CC and)
            (PP (IN by)
              (NP
                (NP (NN determination))
                (PP (IN of)
                  (NP
                    (NP (NN T) (NN cell))
                    (CC or)
                    (NP (NN B) (NN cell) (NN receptor) (NN gene) (NN rearrangement) (NN status))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN majority))
        (PP (IN of)
          (NP (JJ normal) (NN mouse) (JJ thymic) (NN T) (NNS cells))))
      (VP (VBP express)
        (NP
          (NP
            (NP
              (NP (CC both)
                (NP (DT the) (NN CD4))
                (CC and)
                (NP (NN CD8)))
              (NN surface) (NNS markers))
            (PRN (-LRB- -LRB-)
              (NP (JJ double) (JJ positive) (NN -LSB-DP) (-RRB- -RSB-) (NNS cells))
              (-RRB- -RRB-)))
          (, ,)
          (CONJP (RB as) (RB well) (IN as))
          (NP
            (NP
              (NP (DT the) (JJ pan-T) (NN cell) (NN marker) (NN Thy1))
              (PRN (-LRB- -LRB-)
                (NP (NN CD90))
                (-RRB- -RRB-)))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NN wt))
                (PP (IN in)
                  (NP (NN Figure) (CD 5))))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN situation))
        (PP (IN with)
          (NP
            (NP (DT the) (NNS thymomas))
            (PP (IN of)
              (NP (NN invertor) (NNS mice))))))
      (VP (VBD varied)
        (PP
          (PP
            (PP (IN from)
              (NP
                (NP
                  (ADVP (RB mainly))
                  (NP
                    (NP (JJ CD4+CD8+) (NN DP) (NNS cells))
                    (PRN (-LRB- -LRB-)
                      (PP (FW e.g.) (, ,)
                        (NP (NN M2)))
                      (PP (IN in)
                        (NP (NN Figure) (CD 5)))
                      (-RRB- -RRB-))))
                (TO to)
                (NP
                  (ADVP (RB mainly))
                  (NP (JJ CD8+) (JJ single) (JJ positive) (-LRB- -LRB-) (NN SP) (-RRB- -RRB-) (NNS cells)))))
            (PRN (-LRB- -LRB-)
              (PP (FW e.g.) (, ,)
                (NP (NN M3)))
              (PP (IN in)
                (NP (NN Figure) (CD 5)))
              (-RRB- -RRB-)))
          (PP (TO to)
            (NP
              (ADJP (RB mainly) (JJ double) (JJ negative))
              (NNS cells)))
          (PRN (-LRB- -LRB-)
            (PP (FW e.g.) (, ,)
              (NP (NN M4)))
            (PP (IN in)
              (NP (NN Figure) (CD 5)))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD Thirteen))
        (PP (IN of)
          (NP
            (NP (DT the) (NN cohort))
            (PP (IN of)
              (NP (CD 25) (JJ leukaemic) (NN invertor) (NNS mice))))))
      (VP (VBD were)
        (VP (VBN analysed)
          (PP (IN for)
            (NP (PRP$ their) (JJ thymic) (NN T) (NN cell) (NN profile)))
          (PP (IN by)
            (NP
              (NP (NN FACS))
              (PRN (-LRB- -LRB-)
                (VP (VBN summarized)
                  (PP (IN in)
                    (NP (NN Table) (CD 1))))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN While)
        (S
          (NP (PRP we))
          (VP (VBD found)
            (NP (DT either) (JJ CD8+) (NN SP)
              (CC or)
              (JJ CD4+CD8+) (NN DP) (NNS thymomas)))))
      (, ,)
      (NP (NN none))
      (VP (VBD showed)
        (NP (DT a) (JJ CD4+) (NN SP) (NN phenotype))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD Two))
        (PP (IN of)
          (NP (DT the) (NNS thymomas))))
      (VP (VBD had)
        (NP
          (NP (DT a) (JJ mixed) (NN phenotype))
          (VP (VBG comprising)
            (ADVP (RB mainly))
            (NP (JJ CD8+) (NN SP) (NNS cells))
            (, ,)
            (PP (IN with)
              (NP
                (NP (DT a) (NN sub-population))
                (PP (IN of)
                  (NP
                    (NP (NN DP) (NNS cells))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP
                          (NP (NN M3))
                          (CC and)
                          (NP (NN M6)))
                        (PP (IN in)
                          (NP (NN Table) (CD 1))))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN clonality))
        (PP (IN of)
          (NP (DT these) (NN T) (NN cell) (NNS tumours))))
      (VP (VBD was)
        (VP (VBN assessed)
          (PP (IN by)
            (NP
              (NP (NN filter) (NN hybridisation))
              (PP (IN of)
                (NP (JJ genomic) (NN thymoma) (NN DNA)))
              (PP (IN with)
                (NP
                  (NP
                    (NP (DT a)
                      (NP (NN T) (NN cell) (NN receptor))
                      (NN β) (NN probe))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Tcrb))
                      (-RRB- -RRB-)))
                  (PP (IN from)
                    (NP (DT the) (NN Jβ2) (NN region)
                      (NP
                        (NP (CD -LSB-40) (-RRB- -RSB-))
                        (PRN (-LRB- -LRB-)
                          (ADVP (RB diagrammatically))
                          (VP (VBN shown)
                            (PP (IN in)
                              (NP (NN Figure) (NN 3B))))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN probe))
      (VP (VBZ detects)
        (NP
          (NP (DT a) (JJ 5-kb) (NN band))
          (PP (IN in)
            (NP
              (NP (JJ non-lymphoid) (NN DNA))
              (VP (VBG corresponding)
                (PP (TO to)
                  (NP (DT the) (JJ intact) (NN Tcrb) (NN gene)))))))))
    (: ;)
    (S
      (SBAR (IN if)
        (S
          (NP
            (NP
              (NP (NN V-D-J))
              (CC or)
              (NP (NN D-J)))
            (NNS joins))
          (VP (VBP have)
            (VP (VBN occurred)))))
      (, ,)
      (NP (JJ new) (NN restriction) (NNS fragments))
      (VP (VBP are)
        (VP (VBN created) (, ,)
          (S
            (VP (VBG giving)
              (NP (NN rise))
              (PP (TO to)
                (NP
                  (NP (JJ “rearranged) (NN '') (NNS bands))
                  (PP (IN on)
                    (NP (DT the) (NN hybridisation) (NN autoradiograph))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Figure) (NN 3B))
      (VP (VBZ shows)
        (NP
          (NP (DT the) (NN rearrangement) (NN status))
          (PP (IN of)
            (NP
              (NP (CD 12))
              (PP (IN of)
                (NP (DT the) (JJ Ews-ERG) (NNS thymomas))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT All))
        (PP (IN except)
          (NP
            (NP
              (NP
                (NP (CD one))
                (PRN (-LRB- -LRB-)
                  (NP (NN M9))
                  (-RRB- -RRB-)))
              (VP (VBD showed)
                (NP
                  (QP (IN at) (JJS least) (CD one))
                  (JJ rearranged) (NN Jβ2) (NN allele))))
            (CC and)
            (NP (JJ several)))))
      (VP (VBP have)
        (NP
          (NP (CD two) (JJ rearranged) (NNS alleles))
          (PRN (-LRB- -LRB-)
            (PP (FW e.g.) (, ,)
              (NP (NN M18)))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Variable) (NNS amounts))
        (PP (IN of)
          (NP (JJ residual) (NN germ) (NN line) (NN allele))))
      (VP (VBD were)
        (ADJP (JJ present))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN Tcrb) (NN rearrangement) (NN status))
        (PP (IN of)
          (NP
            (NP (DT the) (NN cohort))
            (PP (IN of)
              (NP (NN Ews-ERG) (JJ leukaemic) (NNS mice))))))
      (VP (VBZ is)
        (VP (VBN summarized)
          (PP (IN in)
            (NP (NN Table) (CD 1))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN addition)))
      (, ,)
      (NP
        (NP (DT the) (NN status))
        (PP (IN of)
          (NP (DT the) (NN immunoglobulin) (NN locus))))
      (VP (VBD was)
        (VP (VBN examined)
          (PP (IN with)
            (NP
              (NP (DT a) (NN probe))
              (PP (IN from)
                (NP
                  (NP (DT the) (NN region))
                  (PP (IN between)
                    (NP (NN JH)
                      (CC and)
                      (NN Cμ) (NNS segments)
                      (NP
                        (NP (CD -LSB-41) (-RRB- -RSB-))
                        (PRN (-LRB- -LRB-)
                          (S
                            (VP (VB see)
                              (NP (NN Figure) (NN 3C))))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Single) (NN Igh) (NN allele) (NNS rearrangements))
      (VP (VBD were)
        (VP (VBN observed)
          (PP (IN in)
            (NP
              (NP (RB about) (NN half))
              (PP (IN of)
                (NP
                  (NP (DT the) (NN cohort))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Table) (CD 1))
                    (-RRB- -RRB-))))))
          (, ,)
          (PP (VBG including)
            (NP
              (NP (NNS ones))
              (SBAR
                (WHPP (IN in)
                  (WHNP (WDT which)))
                (S
                  (NP
                    (NP (NN FACS) (NN analysis))
                    (CC and)
                    (NP (NN Tcrb) (NN clonality) (NNS hybridisations)))
                  (VP (VBD showed)
                    (NP (DT the) (NNS tumours))
                    (S
                      (VP (TO to)
                        (VP (VB be)
                          (NP (JJ clonal) (NN T) (NN cell) (NNS malignancies)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN Igh) (NNS rearrangements))
      (VP (VBP are)
        (ADVP (RB therefore))
        (ADJP (JJ likely)
          (S
            (VP (TO to)
              (VP (VB be)
                (NP (JJ abortive) (NNS rearrangements))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Confirmation))
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN Tcrb) (NNS rearrangements))
              (VP (VBN observed)
                (PP (IN by)
                  (NP (NNS hybridisations)))))
            (VP (VBD were)
              (PP (JJ due) (TO to)
                (NP (JJ productive) (NN V-D-J) (NNS joins)))))))
      (VP (VBD was)
        (VP (VBN made)
          (PP (IN by)
            (NP
              (NP (NN sequence) (NN analysis))
              (PP (IN of)
                (NP
                  (NP (DT the) (NN Tcrb) (NNS genes))
                  (PP (IN in)
                    (NP
                      (NP (CD four))
                      (PP (IN of)
                        (NP (DT the) (NNS cases))))))))))))
    (. .)))

(
  (S
    (NP
      (NP (NN PCR) (NN amplification))
      (PP (IN from)
        (NP (NN thymoma) (NN DNA))))
    (VP (VBD was)
      (VP (VBN carried)
        (PRT (RP out))
        (PP (IN with)
          (NP
            (NP
              (NP
                (NP (NNS pools))
                (PP (IN of)
                  (NP
                    (NP (JJ Vβ) (NNS primers))
                    (CC and)
                    (NP
                      (NP (DT a) (NN Jβ2) (JJ reverse) (NN primer))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (NN primer) (NNS sequences))
                          (PP (IN from)
                            (NP (NN -LSB-42,43))))
                        (-RRB- -RSB-) (-RRB- -RRB-))))))
              (CC and)
              (NP (NNS sequences)))
            (VP (VBN identified)
              (PP (IN with)
                (NP (DT the) (NNP ImMunoGeneTics) (NN database) (CD -LSB-44,45) (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Table) (CD 2))
      (VP (VBZ shows)
        (NP
          (NP (DT the) (NN V-D-J) (NN junctional) (NNS sequences))
          (VP (VBG indicating)
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP
                  (NP (JJ productive) (NN T) (NN cell) (NN receptor) (CD β))
                  (NNS genes))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT all) (NNS cases)))
      (, ,)
      (NP (NN N-region) (NN diversity))
      (VP (VBZ is)
        (ADJP (JJ present)
          (PP (IN between)
            (NP (DT the) (NN V-D)
              (CC and)
              (NN D-J) (NNS junctions))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP
          (NP (DT the) (NN thymoma) (NN DNA))
          (PP (IN from)
            (NP (NN M2)))))
      (, ,)
      (NP (DT a) (JJ non-productive) (NN join))
      (VP (VBZ has)
        (ADVP (RB also))
        (VP (VBN occurred) (, ,)
          (PP (IN in)
            (NP
              (NP (NN addition))
              (PP (TO to)
                (NP (DT the) (JJ productive) (NN one)))))
          (, ,)
          (S
            (VP (VBG resulting)
              (PP (IN in)
                (NP (DT an) (JJ out-of-frame) (NN joint))))))))
    (. .)))

(
  (S
    (NP (NN Discussion))))

(
  (S
    (S
      (NP
        (NP (JJ Human) (NNS cancers))
        (PP (IN of)
          (NP (JJ mesenchymal) (NN origin))))
      (VP (VBP involve)
        (NP
          (NP (DT the) (NN EWS) (NN gene))
          (PP (IN with)
            (NP
              (NP (JJ various) (NN partner) (NNS genes))
              (, ,)
              (PP (JJ such) (IN as)
                (PP (IN in)
                  (NP (DT the) (NN chromosomal) (NN translocation)
                    (NP
                      (NP (NN t) (-LRB- -LRB-) (CD 21) (: ;) (CD 22) (-RRB- -RRB-))
                      (PRN (-LRB- -LRB-)
                        (NP (CD q22) (: ;) (CD q12) (-RRB- -RRB-)
                          (SBAR
                            (WHADVP (WRB where))
                            (S
                              (NP (NN EWS))
                              (VP (VBZ fuses)
                                (PP (IN with)
                                  (NP (NN ERG)))
                                (S
                                  (VP (TO to)
                                    (VP (VB encode)
                                      (NP (DT a) (JJ novel) (NN EWS-ERG) (NN fusion) (NN protein) (CD -LSB-18)))))))))
                        (-RRB- -RSB-)))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN addition)))
      (, ,)
      (NP
        (NP (NN EWS) (NN gene) (NNS fusions))
        (PP (IN with)
          (NP (JJ various) (NNS partners))))
      (VP (VBP are)
        (VP (VBN described)
          (PP (IN in)
            (NP
              (NP (JJ clear) (NN cell) (NN sarcoma))
              (, ,)
              (NP (JJ desmoplastic) (JJ small) (NN round) (NN cell) (NNS tumours))
              (, ,)
              (NP (NN chondrosarcoma))
              (, ,)
              (CC and)
              (NP (JJ myxoid) (NN liposarcoma)))))
        (, ,)
        (S
          (VP (VBG suggesting)
            (SBAR
              (SBAR (IN that)
                (S
                  (NP (NN EWS) (NN fusion) (NNS proteins))
                  (VP (VBP are)
                    (ADJP (JJ functional)
                      (PP (IN for)
                        (NP
                          (NP (JJ various) (NN cell) (NNS types))
                          (PP (IN of)
                            (NP (JJ mesenchymal) (NN origin)))))))))
              (CC and)
              (SBAR (IN that)
                (S
                  (NP
                    (NP (NNS restrictions))
                    (PP (IN in)
                      (NP (NNS humans))))
                  (VP (VBP are)
                    (VP (VBN dictated)
                      (ADVP (RB largely))
                      (PP (IN by)
                        (NP
                          (NP (DT the) (NNS cells))
                          (SBAR
                            (WHPP (IN in)
                              (WHNP (WDT which)))
                            (S
                              (NP (DT the) (JJ chromosomal) (NNS translocations))
                              (VP (VBP occur)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD tested)
        (NP
          (NP (DT the) (NN hypothesis))
          (PP (IN of)
            (NP (NN cell) (NN type) (NN specificity))))
        (PP (IN by)
          (S
            (VP (VBG assessing)
              (NP
                (NP (DT the) (JJ possible) (NN universality))
                (PP (IN of)
                  (NP (NN EWS-ERG))))
              (PP (IN as)
                (NP (DT an) (NN oncogene))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (JJ experimental) (NN system))
      (VP (VBD was)
        (VP (VBN designed)
          (S
            (VP (TO to)
              (VP (VB invoke)
                (NP
                  (NP
                    (ADJP
                      (ADJP (JJ conditional))
                      (, ,)
                      (ADJP (JJ cell-specific)))
                    (NN expression))
                  (PP (IN of)
                    (NP (DT the) (NN Ews-ERG) (NN fusion))))
                (S
                  (VP (TO to)
                    (VP (VB analyse)
                      (NP
                        (NP (DT the) (NN target) (NN cell))
                        (SBAR
                          (WHPP (IN in)
                            (WHNP (WDT which)))
                          (S
                            (NP (PRP it))
                            (VP (MD can)
                              (VP (VB function)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Consistent) (NN EWS-ERG) (NN occurrence))
        (PP (IN in)
          (NP (JJ human) (NNS sarcomas))))
      (VP (VBZ suggests)
        (SBAR (IN that)
          (S
            (NP (PRP it))
            (VP (MD may)
              (ADVP (RB only))
              (VP (VB function)
                (PP (IN in)
                  (NP
                    (NP (JJ mesenchymal) (NNS cells))
                    (, ,)
                    (SBAR
                      (WHADVP (WRB where))
                      (S
                        (NP (PRP it))
                        (VP (MD may)
                          (VP (VB function)
                            (PP
                              (PP (IN in)
                                (NP
                                  (NP (NN initiation))
                                  (PP (IN of)
                                    (NP (DT the) (NN cancer)))))
                              (CONJP (RB as) (RB well) (IN as))
                              (PP (IN in)
                                (NP
                                  (NP (NN maintenance))
                                  (PP (IN of)
                                    (NP
                                      (NP (DT the) (NN cancer) (NN stem) (NN cell))
                                      (PRN (-LRB- -LRB-)
                                        (PP (FW i.e.))
                                        (, ,)
                                        (NP
                                          (NP (NNS cells))
                                          (PP (IN within)
                                            (NP
                                              (NP (DT the) (NN tumour))
                                              (SBAR
                                                (WHNP (WDT that))
                                                (S
                                                  (VP
                                                    (VP (VBP have)
                                                      (NP (JJ self-renewing) (NN capacity)))
                                                    (CC and)
                                                    (VP (VBP maintain)
                                                      (NP (DT the) (NN tumour)))))))))
                                        (-RRB- -RRB-)))))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (NNS results))
      (VP (VBP show)
        (SBAR (IN that)
          (S
            (NP (NNS lymphomas))
            (VP (VBP arise)
              (SBAR
                (WHADVP (WRB when))
                (S
                  (NP (NN Ews-ERG))
                  (VP (VBZ is)
                    (ADVP (RB aberrantly))
                    (VP (VBN expressed)
                      (PP (IN in)
                        (NP
                          (NP (DT the) (VBN committed) (NNS cells))
                          (PP (IN of)
                            (NP (DT the) (JJ lymphoid) (NN lineage))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN Ews-ERG) (NN invertor) (NN allele))
      (VP (VBD was)
        (VP (VBN activated)
          (PP (IN in)
            (NP (NNS lymphocytes)))
          (, ,)
          (S
            (VP (VBG using)
              (NP
                (NP (DT the) (NN Rag1-Cre) (NN knock-in) (NNS mice))
                (CD -LSB-36) (-RRB- -RSB-)))))
        (, ,)
        (S
          (VP (TO to)
            (VP (VB determine)
              (SBAR (IN if)
                (S
                  (NP (JJ lymphoid) (NNS malignancies))
                  (VP (MD would)
                    (VP (VB arise))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD found)
        (SBAR (IN that)
          (S
            (NP (NN invertor) (NN Ews-ERG) (NNS mice))
            (VP (VBP develop)
              (NP (JJ clonal) (NN T) (NN cell) (NNS malignancies)))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT The) (NN T) (NNS cells))
        (VP (VBD were)
          (PP (IN of)
            (NP (JJ varying) (NNS phenotypes)))))
      (CC but)
      (S
        (NP
          (NP (DT the) (NN majority))
          (PP (IN of)
            (NP (NNS cases))))
        (VP
          (VP (VBD expressed)
            (NP (NN CD8))
            (PP (IN on)
              (NP (DT the) (NN cell) (NN surface))))
          (CC and)
          (VP (VBD had)
            (NP
              (NP (JJ productive) (NN V-D-Jβ) (NNS rearrangements))
              (, ,)
              (ADJP (JJ indicative)
                (PP (IN of)
                  (NP (JJ mature) (NN T) (NNS cells)))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Since)
        (S
          (NP
            (NP (JJ Cre-mediated) (NN inversion))
            (PP (IN through)
              (NP (JJ loxP) (NNS sites))))
          (VP (VBZ recreates)
            (NP (DT the) (JJ loxP) (NN sequence)))))
      (, ,)
      (NP (EX there))
      (VP (VBZ is)
        (NP
          (NP (NN potential))
          (PP (IN for)
            (NP
              (NP (DT the) (NN cassette))
              (PP (TO to)
                (NP (NN flip))))))
        (ADVP
          (ADVP (RB back))
          (CC and)
          (ADVP (RB forth)))
        (PP (IN with)
          (NP (JJ continued) (NN Cre) (NN expression)))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (VBD had)
        (NP (DT no) (JJ obvious) (JJ deleterious) (NN effect))
        (PP (IN on)
          (NP
            (NP (NN tumourigenesis))
            (PP (IN in)
              (NP (DT the) (JJ Ews-ERG) (NNS invertors)))))
        (SBAR (IN as)
          (S
            (VP (VBN judged)
              (PP (IN by)
                (NP
                  (NP (JJ various) (NNS criteria))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NN tumour) (NN penetrance))
                      (, ,)
                      (NP (JJ consistent) (NN T) (NN cell) (NN phenotype))
                      (, ,)
                      (CC and)
                      (NP (NN pathology)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (ADVP (RB Thus))
    (, ,)
    (NP
      (NP (DT the) (NN invertor) (NN allele))
      (PP (IN of)
        (NP (JJ transformed) (NNS cells))))
    (VP (MD may)
      (VP (VB be)
        (ADJP (JJ fixed)
          (PP (IN in)
            (NP
              (NP (DT the) (JJ correct) (NN orientation))
              (PP (IN for)
                (NP
                  (NP (NN synthesis))
                  (PP (IN of)
                    (NP (NN Ews-ERG) (NN mRNA))))))))
        (SBAR
          (WHADVP (WRB when))
          (S
            (NP (NN Rag1-Cre))
            (VP (VBZ is)
              (ADVP (RB no) (RBR longer))
              (ADJP (JJ effective)))))))
    (. .)))

(
  (S
    (S
      (PP (IN On)
        (NP (DT the) (JJ other) (NN hand)))
      (, ,)
      (NP
        (NP (DT the) (NN lack))
        (PP (IN of)
          (NP (JJ CD4+) (NN SP) (NNS thymomas))))
      (VP (VBZ is)
        (ADJP (JJ difficult)
          (S
            (VP (TO to)
              (VP (VBP encompass)
                (PP (IN with)
                  (NP (DT this) (NN explanation)))))))
        (, ,)
        (S
          (VP (VBG suggesting)
            (SBAR (IN that)
              (S
                (NP (JJ other) (JJ biological) (NNS mechanisms))
                (VP (MD may)
                  (VP (VB be)
                    (VP (VBN involved)
                      (PP (IN in)
                        (NP (DT this) (NN bias))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN Rag1-Cre) (NN mouse) (NN line))
        (VP (VBN used)))
      (ADVP (RB constitutively))
      (VP (VBZ expresses)
        (NP (NN Cre))
        (PP (IN in)
          (NP (JJ lymphoid) (NNS cells) (CD -LSB-36) (-RRB- -RSB-)))))
    (, ,)
    (CC and)
    (S
      (NP (DT the) (VBG resulting) (NN Ews-ERG) (NN fusion))
      (VP (VBZ causes)
        (NP (NN T) (NN lymphocyte) (NNS tumours))
        (PP (IN in)
          (NP
            (NP (NNS mice))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (VBZ is) (RB not)
                  (VP (VBN known)
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN spectrum))
                        (PP (IN of)
                          (NP (JJ EWS-associated) (JJ human) (NNS cancers)))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN On)
        (NP (DT the) (JJ other) (NN hand)))
      (, ,)
      (NP (NN FUS-ERG))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN found)
            (PP (IN in)
              (NP (NNS leukaemias)))
            (, ,)
            (PP (IN albeit)
              (NP (NN myeloid) (NN type) (CD -LSB-26,46))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (VBZ implies)
        (SBAR (IN that)
          (S
            (NP (DT the) (JJ EWS-FUS) (NN fusion) (NNS proteins))
            (VP (MD could)
              (VP (VB be)
                (ADJP (JJ effective))
                (PP (IN in)
                  (NP
                    (NP (DT a) (NN spectrum))
                    (PP (IN of)
                      (NP (NN cell) (NNS types)))
                    (, ,)
                    (VP
                      (ADVP (JJR broader) (IN than) (RB normally))
                      (VBN seen)
                      (PP (IN in)
                        (NP
                          (NP (JJ human) (NNS malignancies))
                          (PRN (-LRB- -LRB-)
                            (PP (FW i.e.))
                            (, ,)
                            (NP
                              (NP (NNS sarcomas))
                              (CC and)
                              (NP (JJ myeloid) (NNS leukaemias)))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT some) (NNS cells)))
      (, ,)
      (NP (PRP it))
      (VP (MD may)
        (VP (VB be)
          (SBAR (IN that)
            (S
              (S
                (NP (NN EWS-FUS) (NNS fusions))
                (VP (VBP are)
                  (ADJP (JJ lethal))))
              (CC and)
              (S
                (ADVP (RB thus))
                (NP
                  (NP (DT those) (NNS cells))
                  (VP (VBG acquiring)
                    (NP (DT a) (NN translocation))))
                (VP (MD would)
                  (VP (VBP die)))))))))
    (: ;)
    (S
      (PP (IN in)
        (NP (NNS others)))
      (, ,)
      (NP (DT the) (NN fusion) (NN protein))
      (VP
        (VP (MD may)
          (VP (VB be)
            (VP (VBN tolerated))))
        (CC and)
        (ADVP (RB thus))
        (VP (MD may)
          (VP (VB become)
            (NP (NNS tumours))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (DT this) (NN respect)))
    (, ,)
    (NP
      (NP (DT the) (NN absence))
      (PP (IN of)
        (NP
          (NP (NN B) (NN cell) (NNS tumours))
          (PP (IN in)
            (NP (DT the) (JJ Ews-ERG) (NNS invertors))))))
    (VP (VBZ is)
      (PP (IN of)
        (NP (NN interest)))
      (SBAR (IN as)
        (S
          (NP (DT both)
            (NP
              (NP (NN B))
              (CC and)
              (NP (NN T)))
            (NNS cells))
          (VP (VBP undergo)
            (NP
              (NP (NN inversion))
              (PP (IN of)
                (NP
                  (NP (DT the) (NN Ews-ERG) (NN cassette))
                  (PRN (-LRB- -LRB-)
                    (S
                      (VP (VB see)
                        (NP (NN Figure) (CD 4))))
                    (-RRB- -RRB-)))))
            (SBAR (IN because)
              (S
                (NP (NN Rag1-Cre))
                (VP (VBZ is)
                  (VP (VBN expressed)
                    (PP (IN in)
                      (NP (DT both) (NN cell) (NNS types)
                        (NP
                          (NP (CD -LSB-36) (-RRB- -RSB-))
                          (PRN (-LRB- -LRB-)
                            (S
                              (VP (VB see)
                                (NP (NN Figure) (NN S3))))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN absence))
        (PP (IN of)
          (NP (NN B) (NN cell) (NNS tumours))))
      (VP (MD may)
        (VP (VB reflect)
          (NP
            (NP (NN toxicity))
            (PP (IN of)
              (NP (DT the) (NN fusion) (NN protein)))
            (PP (IN for)
              (NP (NN B) (NNS cells))))
          (SBAR (IN although)
            (S
              (NP (DT this))
              (VP (VBZ seems)
                (ADJP (JJ unlikely)
                  (VP (VBN given)
                    (SBAR (IN that)
                      (S
                        (NP (PRP we))
                        (VP (MD can)
                          (VP (VB detect)
                            (NP
                              (NP (DT the) (NN fusion) (NN mRNA))
                              (PP (IN in)
                                (NP (VBN selected) (NN B220+) (NN B) (NNS lymphocytes))))
                            (PRN (-LRB- -LRB-)
                              (S
                                (VP (VB see)
                                  (NP (NN Figure) (CD 4))))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Alternatively))
      (, ,)
      (NP (PRP it))
      (VP (MD may)
        (VP (NN mean)
          (SBAR
            (SBAR (IN that)
              (S
                (NP (NN Ews-ERG))
                (VP (VBZ does) (RB not)
                  (VP (VB function)
                    (PP (IN in)
                      (NP (NN B) (NNS cells)))))))
            (CC or)
            (SBAR (IN that)
              (S
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN B) (NN cell) (NNS tumours))))
                (VP (VBZ is)
                  (VP (VBN inhibited)
                    (PP (IN by)
                      (NP
                        (NP (DT the) (NN T) (NN cell) (NNS malignancies))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD may)
                              (VP
                                (VP (VB arise)
                                  (ADVP (RBR earlier)))
                                (CC and)
                                (ADVP (RB then))
                                (VP (VB dominate)
                                  (NP (DT the) (JJ lymphoid) (NN compartment)))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN ability))
        (PP (IN of)
          (NP (NN Ews-ERG)))
        (S
          (VP (TO to)
            (ADVP (RB specifically))
            (VP (VB cause)
              (NP (NN B) (NN cell) (NNS tumours))))))
      (VP (MD could)
        (VP (VB be)
          (VP (VBN evaluated)
            (PP (IN by)
              (S
                (VP (VBG using)
                  (NP
                    (NP (JJ B-cell-specific) (JJ Cre-expressing) (NN mouse) (NNS lines))
                    (PP (JJ such) (IN as)
                      (NP (NN CD19-Cre)))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (NNS results))
      (VP (VBP show)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN Ews-ERG) (NN fusion))
              (, ,)
              (VP
                (ADVP (RB normally))
                (VBN restricted)
                (PP (TO to)
                  (NP
                    (NP (NNS sarcomas))
                    (PP (IN in)
                      (NP (NNS humans))))))
              (, ,))
            (VP (MD can)
              (VP (VB initiate)
                (NP (NN T) (NN lymphocyte) (NNS tumours))
                (, ,)
                (SBAR (IN if)
                  (ADVP (RB conditionally))
                  (VP (VBN expressed)
                    (PP (IN in)
                      (NP (VBN committed) (JJ lymphoid) (NNS cells)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Leukaemogenesis))
        (PP (IN in)
          (NP (NN Ews-ERG) (NN invertor) (NNS mice))))
      (ADVP (RB thus))
      (VP (VBZ concurs)
        (PP (IN with)
          (NP (DT the) (NN hypothesis)
            (SBAR (IN that)
              (S
                (NP (NN EWS) (NNS fusions))
                (VP (MD can)
                  (VP (VB cause)
                    (NP
                      (NP (NN neoplasia))
                      (VP (VBG arising)
                        (PP (IN in)
                          (NP (JJ various) (NN cell) (NNS types)))))))))))))
    (. .)))

(
  (S
    (ADVP (RB Further))
    (, ,)
    (NP (PRP$ our) (NNS data))
    (VP (VBP imply)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (JJ cellular) (NN context))
            (PP (IN of)
              (NP
                (NP (JJ EWS-associated) (JJ chromosomal) (NNS translocations))
                (PP (IN in)
                  (NP (NNS humans))))))
          (VP (VBZ does) (RB not)
            (VP (VB have)
              (S
                (VP (TO to)
                  (VP (VB be)
                    (NP
                      (NP (DT a) (NN stem) (NN cell))
                      (CC or)
                      (NP (RB even) (DT a) (JJ multi-potent) (NN progenitor)))
                    (, ,)
                    (SBAR (IN as)
                      (S
                        (NP
                          (NP (VBN committed) (NN lymphocyte) (NNS precursors))
                          (VP (VBG expressing)
                            (NP (NN Rag) (NN recombinase) (NNS genes))))
                        (VP (VBP are)
                          (NP
                            (NP (DT the) (JJ leukaemic) (NNS precursors))
                            (PP (IN in)
                              (NP (PRP$ our) (JJ invertor) (NN model)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ same) (NNS conclusions))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN applied)
            (PP (TO to)
              (NP
                (NP (JJ FUS-associated) (JJ chromosomal) (NNS translocations))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (VBP seem)
                      (S
                        (VP (TO to)
                          (VP (VB be)
                            (ADJP (RB largely) (JJ interchangeable)
                              (PP (IN with)
                                (NP (NNS EWS)))))))
                      (, ,)
                      (PP (VBN given)
                        (NP
                          (NP (DT the) (NN spectrum))
                          (PP (IN of)
                            (NP
                              (NP (NNS cancers))
                              (SBAR
                                (WHPP (IN in)
                                  (WHNP (WDT which)))
                                (S
                                  (NP (DT these))
                                  (VP (VBP are)
                                    (VP (VBN found)
                                      (NP (CC and)
                                        (NP
                                          (NP (DT the) (NN relatedness))
                                          (PP (IN of)
                                            (NP (NN FUS-))))
                                        (CC and)
                                        (NP
                                          (NP (JJ EWS-coded) (NNS proteins))
                                          (NP (CD -LSB-24,25) (-RRB- -RSB-)))))))))))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (NP
        (NP
          (NP (NN EWS))
          (CC or)
          (NP (NN FUS)))
        (JJ chromosomal) (NNS translocations))
      (ADVP (RB probably))
      (VP (VBP arise)
        (ADVP (RBR more))
        (PP
          (PP (IN by)
            (NP
              (NP (NN virtue))
              (PP (IN of)
                (NP
                  (NP (NN accessibility))
                  (PP (IN of)
                    (NP (DT the) (NNS genes)))
                  (PP (TO to)
                    (NP (JJ chromosomal) (NNS translocations)))))))
          (CONJP (IN than))
          (PP (IN by)
            (NP
              (NP (DT the) (JJ precise) (JJ cellular) (NN specificity))
              (PP (IN of)
                (NP (DT the) (JJ resultant) (NN fusion) (NNS proteins))))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Materials))
      (CC and)
      (NP (NNS Methods)))))

(
  (S
    (S
      (NP (DT The) (NN Ews) (JJ genomic) (NN targeting) (NN clone))
      (VP (VBD was)
        (VP (VBN constructed)
          (PP (IN from)
            (NP
              (NP (JJ γ) (NN phage) (NN DNA))
              (VP (VBN isolated)
                (PP (IN from)
                  (NP (NN mouse) (CD 129) (NN DNA) (NN -LSB-47) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (DT The) (JJ knock-in) (NNS clones))
          (PP (IN for)
            (NP
              (NP (JJ potential) (NN Ews) (NNS fusions))
              (PP (IN with)
                (NP
                  (NP (NN AF9))
                  (, ,)
                  (NP (NN Fli1))
                  (, ,)
                  (NP (NN Chop))
                  (, ,)
                  (CC and)
                  (NP (NN ATF1)))))))
        (VP (VBD were)
          (VP (VBN made)
            (S
              (VP (VBG using)
                (NP (DT a) (NN transfer) (NN vector) (NN pC2A-neo) (CD -LSB-35) (-RRB- -RSB-)))))))
      (, ,)
      (CC and)
      (S
        (NP
          (NP (DT the) (NNS sequences))
          (PP (IN of)
            (NP (DT these) (NN cDNA) (NNS cassettes))))
        (VP (VBP are)
          (VP (VBN given)
            (PP (IN in)
              (NP (NN Figure) (NN S1)))))))
    (. .)))

(
  (S
    (S
      (NP (NN Knock-in))
      (VP (VBD was)
        (VP (VBN achieved)
          (PP (IN by)
            (NP (JJ homologous) (NN recombination)))
          (PP (IN as)
            (NP (VBN described) (NN -LSB-47) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (NP (DT The) (JJ ERG) (NN inversion) (NN knock-in) (NN cassette) (CD -LSB-35) (-RRB- -RSB-))
    (VP (VBD was)
      (VP (VBN prepared)
        (S
          (VP (VBG using)
            (NP
              (NP (NN cDNA))
              (VP (VBN made)
                (PP (IN from)
                  (NP (JJ human) (NN colon) (NN carcinoma)
                    (NP
                      (NP (NN COLO320) (NN mRNA))
                      (PRN (-LRB- -LRB-)
                        (S
                          (NP
                            (NP (DT the) (NN sequence))
                            (PP (IN of)
                              (NP (DT the) (NN ERG) (NN segment)))
                            (, ,)
                            (VP (VBG corresponding)
                              (PP (TO to)
                                (NP
                                  (NP (DT the) (NN part))
                                  (PP (IN of)
                                    (NP (NN ERG)))
                                  (VP (VBN found)
                                    (PP (IN in)
                                      (NP (JJ EWS-ERG) (NN fusion) (NN -LSB-19)))))))
                            (-RRB- -RSB-))
                          (VP (VBZ is)
                            (VP (VBN shown)
                              (S
                                (NP (NN Figure) (NN S1))))))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (DT A) (NN diagram))
          (PP (IN of)
            (NP
              (NP (JJ overall) (NN structure))
              (PP (IN of)
                (NP (DT the) (NN ERG) (NN inversion) (NN cassette))))))
        (VP (VBZ is)
          (VP (VBN shown)
            (PP (IN in)
              (NP (NN Figure) (NN 1A))))
          (, ,)
          (S
            (VP (VBG indicating)
              (NP
                (NP (DT the) (JJ initial) (NN orientation))
                (PP (IN of)
                  (NP
                    (NP (DT the) (JJ ERG) (NN inversion) (NN cassette))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 3′) (TO to) (CD 5′))
                        (PP (IN with)
                          (NP
                            (NP (NN respect))
                            (PP (TO to)
                              (NP (NN Ews))))))
                      (-RRB- -RRB-)))))))))
      (CC and)
      (S
        (NP (DT this))
        (VP (VBD was)
          (VP (VBN determined)
            (PP (IN by)
              (NP
                (NP
                  (NP (NN restriction) (NN site))
                  (NN mapping))
                (CC and)
                (NP (JJ genomic) (NN DNA) (NN sequencing))))))))
    (. .)))

(
  (S
    (S
      (PP (IN After)
        (NP
          (NP (NN identification))
          (PP (IN of)
            (NP (VBN targeted) (NN ES) (NNS cells)))))
      (, ,)
      (S
        (NP (DT these))
        (VP (VBD were)
          (VP (VBN injected)
            (PP (IN into)
              (NP (NN C57BL/6) (NNS blastocysts))))))
      (, ,)
      (S
        (NP (JJ chimaeric) (NNS mice))
        (VP (VBD were)
          (VP (VBN produced))))
      (, ,)
      (CC and)
      (S
        (NP
          (NP (NN germ) (NN line) (NN transmission))
          (PP (IN of)
            (NP (DT the) (NN inversion) (NN knock-in) (NN allele))))
        (VP (VBD was)
          (VP (VBN obtained)))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS mice))
      (VP (VBD were)
        (VP (VBN bred)
          (PP (IN with)
            (NP
              (NP (NNS mice))
              (VP (VBG expressing)
                (NP (NN Cre))
                (PP (IN from)
                  (NP (DT a) (NN Rag1) (NN knock-in) (NN -LSB-36))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Specificity))
        (PP (IN of)
          (NP
            (NP (NN expression))
            (PP (IN of)
              (NP (DT the) (NN Rag1-Cre) (NN allele))))))
      (VP
        (VP (VBZ has)
          (ADVP (RB previously))
          (VP (VBN been)
            (VP (VBN described)
              (NP (CD -LSB-36) (-RRB- -RSB-)))))
        (CC and)
        (VP (VBD was)
          (VP (VBN sustained)
            (S
              (VP (VBG using)
                (NP (DT the) (NN ROSA26-R) (NN reporter) (NNS mice)
                  (NP
                    (NP (CD -LSB-39) (-RRB- -RSB-))
                    (PRN (-LRB- -LRB-)
                      (S
                        (VP (VB see)
                          (NP (NN Figure) (NN S3))))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (JJ Genomic) (NN DNA))
        (VP (VBD was)
          (VP (VBN prepared)
            (PP (IN from)
              (NP
                (NP (NNS tissues))
                (VP (VBG using)
                  (NP
                    (NP (NN proteinase) (NN K) (NN digestion))
                    (CC and)
                    (NP (NN phenol-chloroform) (NN extraction)))))))))
      (, ,)
      (CC and)
      (S
        (NP (NN filter) (NNS hybridisations))
        (VP (VBD were)
          (VP (VBN carried)
            (PRT (RP out))
            (PP (IN with)
              (NP
                (NP (JJ radiolabelled) (NNS probes))
                (PP (IN as)
                  (NP (VBN described) (NN -LSB-48,49) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS probes))
        (VP (VBN used)
          (S
            (VP (TO to)
              (VP (VB detect)
                (NP
                  (NP (NN antigen) (NN receptor))
                  (NN gene) (NNS rearrangements)))))))
      (VP (VBD were)
        (NP
          (NP
            (NP (DT a)
              (NP (JJ heavy-chain) (NN Ig) (NN μ) (NN intron) (NN enhancer))
              (NN probe))
            (CD -LSB-41) (-RRB- -RSB-))
          (CC and)
          (NP
            (NP (DT a)
              (NP (NN T) (NN cell) (NN receptor))
              (NN Jβ2) (NN probe))
            (CD -LSB-40) (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN T) (NN cell) (NN receptor))
        (NN V-D-Jβ) (NN junction) (NNS sequences))
      (VP (VBD were)
        (VP (VBN obtained)
          (PP (IN by)
            (NP
              (NP
                (NP (NN PCR) (NN amplification))
                (PP (IN from)
                  (NP
                    (NP (NN thymoma) (NN DNA))
                    (PP (IN with)
                      (NP
                        (NP (NNS pools))
                        (PP (IN of)
                          (NP (NN Vβ) (NNS primers))))))))
              (CC and)
              (NP
                (NP (DT a) (JJ Jβ2) (JJ reverse) (NN primer))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NN primer) (NNS sequences))
                    (PP (IN from)
                      (NP (NN -LSB-42,43))))
                  (-RRB- -RSB-) (-RRB- -RRB-))))))))
    (, ,)
    (CC and)
    (S
      (NP (DT the) (NN product))
      (VP (VBD was)
        (VP (VBN fractionated)
          (PP (IN on)
            (NP (NN agarose)))
          (S
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (NN presence))
                  (PP (IN of)
                    (NP (DT a) (JJ single) (VBN amplified) (NN band))))))))))
    (. .)))

(
  (S
    (S
      (S
        (PP (IN In)
          (NP (NN turn)))
        (, ,)
        (NP (DT each) (NN band))
        (VP (VBD was)
          (VP (VBN eluted))))
      (CC and)
      (S
        (NP (DT the) (NN sequence))
        (VP
          (VP (VBN obtained)
            (S
              (VP (VBG using)
                (NP (DT the) (NN Jβ2N) (NN primer) (NN -LSB-43)))
              (-RRB- -RSB-)))
          (CC and)
          (VP (VBN identified)
            (PP (IN by)
              (NP
                (NP (NN comparison))
                (PP (IN with)
                  (NP (DT the) (NNP ImMunoGeneTics) (NN database) (CD -LSB-44,45) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN RT-PCR))
      (VP (VBD was)
        (VP (VBN carried)
          (PRT (RP out))
          (PP (IN on)
            (NP (NN cDNA)))
          (PP (IN as)
            (NP (VBN described) (NN -LSB-34) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP (NN RNA))
      (VP (VBD was)
        (VP (VBN prepared)
          (S
            (VP (VBG using)
              (NP (NN RNeasy))))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP Quiagen))
              (, ,)
              (NP (NNP Valencia) (, ,) (NNP California))
              (, ,)
              (NP (JJ United) (NNS States)))
            (-RRB- -RRB-))
          (PP (IN from)
            (NP
              (NP (NNS cells))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBD were)
                    (VP
                      (VP (VBN labelled)
                        (PP (IN with)
                          (NP (JJ FITC-conjugated) (NNS antibodies))))
                      (CC and)
                      (VP (VBN isolated)
                        (PP (IN by)
                          (NP (NN flow) (NN cytometry)))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NNS Sequences))
        (VP (VBP have)
          (VP (VBN been)
            (VP (VBN described)
              (PP (IN for)
                (NP
                  (NP (NN Pax5))
                  (CC and)
                  (NP (NN CD3) (NN RT-PCR))
                  (NP (NNS primers) (CD -LSB-38) (-RRB- -RSB-))))))))
      (, ,)
      (CC and)
      (S
        (NP
          (NP (DT the) (NNS sequences))
          (PP (IN of)
            (NP (DT the) (NN Ews-ERG) (NNS primers))))
        (VP (VBD were)
          (NP
            (NP
              (NP (JJ 5′-) (NN CCACAGGATGGTAACAAGCCTGC-3′))
              (PRN (-LRB- -LRB-)
                (NP (NN Ews))
                (-RRB- -RRB-)))
            (CC and)
            (NP
              (NP (JJ 5′-) (NN CGAACTTGTAGGCGTAGC-3′))
              (PRN (-LRB- -LRB-)
                (NP (NN ERG))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN hybridisation) (NN probe))
      (VP (VBD was)
        (NP
          (NP (DT a) (JJ 303-bp) (NN fragment))
          (PP (IN of)
            (NP (NN Ews-ERG) (NN residing))))
        (PP (IN within)
          (NP (DT the) (NN RT-PCR) (NN product)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (NN cohort))
        (PP (IN of)
          (NP (NNS mice))))
      (VP (VBD was)
        (VP (VBN established)
          (PP (IN by)
            (S
              (VP (VBG inter-breeding)
                (NP
                  (NP (DT the) (NN Ews-ERG) (NN invertor) (NN line))
                  (PP (IN with)
                    (NP (DT a) (NN Rag1-Cre) (NN line)))
                  (S
                    (LST (CD -LSB-36) (-RRB- -RSB-))
                    (VP (TO to)
                      (VP (VB generate)
                        (NP
                          (NP (NNS littermates))
                          (PP (IN with)
                            (NP
                              (NP
                                (NP (NNP Ews-ERG))
                                (CC +)
                                (NP (NNP Rag1-Cre)))
                              (CC or)
                              (NP (NNP Ews-ERG))
                              (NP (NNS genotypes)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Genotypes))
      (VP (VBD were)
        (VP (VBN determined)
          (S
            (VP (VBG using)
              (NP
                (NP (NN filter) (NN hybridisation))
                (PP (IN of)
                  (NP
                    (NP (JJ genomic) (NN DNA))
                    (PP (IN from)
                      (NP (DT a) (JJ small) (NN tail) (NN biopsy)))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (DT The) (NN health) (NN status))
          (PP (IN of)
            (NP (DT these) (NNS mice))))
        (VP (VBD was)
          (VP (VBN monitored))))
      (, ,)
      (CC and)
      (S
        (SBAR (IN if)
          (S
            (NP
              (NP (NNS signs))
              (PP (IN of)
                (NP (NN ill) (NN health))))
            (VP (VBD appeared))))
        (, ,)
        (S
          (S
            (NP (NNS mice))
            (VP (VBD were)
              (VP (VBN sacrificed))))
          (CC and)
          (S
            (NP (DT a) (NN post-mortem))
            (VP (VBD was)
              (VP (VBN carried)
                (PRT (RP out))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Tissue) (NNS samples))
      (VP (VBD were)
        (VP (VBN removed)
          (PP (IN for)
            (NP (JJ single) (NN cell) (NN preparation)))
          (PP
            (PP (IN for)
              (NP
                (NP (NN determination))
                (PP (IN of)
                  (NP
                    (NP (NN surface) (NN protein) (NN expression))
                    (NN phenotype)))))
            (, ,)
            (PP (IN for)
              (NP (JJ nucleic) (NN acid) (NN preparation)))
            (, ,)
            (CC or)
            (PP (IN for)
              (NP
                (NP (NN fixation))
                (PP (IN in)
                  (NP
                    (NP
                      (ADJP (CD 10) (NN %))
                      (NN formalin))
                    (PP (IN for)
                      (NP (NN histology)))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Blood) (NNS smears))
      (VP (VBD were)
        (VP
          (VP (VBN prepared))
          (CC and)
          (VP (VBN stained)
            (PP (IN with)
              (NP (NN May-Grünwald-Giemsa)))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (NN histology)))
      (, ,)
      (NP (JJ fixed) (NNS tissues))
      (VP (VBD were)
        (ADJP (JJ embedded)
          (PP (IN in)
            (NP
              (NP (NN wax)
                (CC and)
                (NN 0.4-μ) (NNS sections))
              (VP (VBN made))
              (, ,)
              (VP (VBN stained)
                (PP (IN with)
                  (NP
                    (NP (NN haematoxylin))
                    (CC and)
                    (NP (NN eosin))))))))
        (PP (IN after)
          (NP (NN mounting)))
        (PP (IN on)
          (NP (NNS slides)))))
    (. .)))

(
  (S
    (S
      (NP (NN FACS) (NN analysis))
      (VP (VBD was)
        (VP (VBN conducted)
          (S
            (VP (VBG using)
              (NP
                (NP (DT a) (NN FACSCalibur))
                (PP (IN with)
                  (NP
                    (NP (JJ fluorescent) (NNS antibodies))
                    (VP (VBN purchased)
                      (PP (IN from)
                        (NP
                          (NP (NNP BD) (NNP Biosciences))
                          (PRN (-LRB- -LRB-)
                            (NP
                              (NP (NNP San) (NNP Jose))
                              (, ,)
                              (NP (NNP California))
                              (, ,)
                              (NP (JJ United) (NNS States)))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Data))
      (VP (VBD were)
        (VP (VBN analysed)
          (PP (IN with)
            (NP
              (NP (NN CellQuest) (NN software))
              (PRN (-LRB- -LRB-)
                (NP (NNP BD) (NNP Biosciences))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP (NN Western) (NN protein) (NN detection))
      (VP (VBD was)
        (VP (VBN carried) (RP out)
          (SBAR (IN as)
            (S
              (VP (VBN described)
                (NP (CD -LSB-36) (-RRB- -RSB-))
                (S
                  (VP (VBG using)
                    (NP
                      (NP
                        (NP (CD 18) (NNS μg))
                        (PP (IN of)
                          (NP (NN protein)))
                        (PP (IN per)
                          (NP (NNP lane))))
                      (CC and)
                      (NP
                        (NP (NNS proteins))
                        (VP (VBN fractionated)
                          (PP (IN on)
                            (NP
                              (ADJP
                                (QP (CD 4) (NN %) (CD –20))
                                (NN %))
                              (NN SDS-PAGE))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (VBN separated) (NNS proteins))
      (VP (VBD were)
        (ADJP (JJ electro-transferred)
          (PP (TO to)
            (NP
              (NP
                (NP (NN PVDF) (NN nylon) (NNS membranes))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NNP Millipore))
                    (, ,)
                    (NP (NNP Billerica) (, ,) (NNP Massachusetts))
                    (, ,)
                    (NP (JJ United) (NNS States)))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (NP (JJ specific) (NNS proteins))
                (VP (VBN detected)
                  (S
                    (VP (VBG using)
                      (NP
                        (NP
                          (NP (JJ anti-Ews) (NN antibody))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP Santa) (NNP Cruz) (NN Biotechnology) (, ,) (NNP Santa) (NNP Cruz) (, ,) (NNP California))
                            (, ,)
                            (NP (JJ United) (NNS States))
                            (: ;)
                            (S
                              (VP (VBN raised)
                                (PP (IN against)
                                  (NP
                                    (NP (DT the) (NN amino) (NN terminus))
                                    (PP (IN of)
                                      (NP (NN Ews)))))))
                            (-RRB- -RRB-)))
                        (CC or)
                        (NP
                          (NP (JJ anti-ERG) (NN antibody))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP Santa) (NNP Cruz) (NN Biotechnology))
                            (: ;)
                            (S
                              (VP (VBN raised)
                                (PP (IN against)
                                  (NP
                                    (NP (DT the) (NN carboxy) (NN terminus))
                                    (PP (IN of)
                                      (NP (NN ERG)))))))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Antibody))
        (VP (VBD bound)
          (PP (TO to)
            (NP (NN filter)))))
      (VP (VBD was)
        (VP (VBN detected)
          (S
            (VP (VBG using)
              (NP
                (NP (JJ secondary) (NNS antibodies))
                (CC and)
                (NP (NN ECL)))
              (PP (IN as)
                (VP (VBN described)
                  (PP (IN by)
                    (NP (DT the) (NN manufacturer)))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP Amersham) (NNP Biosciences) (, ,) (NNP Amersham))
                      (, ,)
                      (NP (JJ United) (NN Kingdom)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure))
      (CC and)
      (NP (NN Table))
      (NP (NNS captions)))))

(
  (S
    (NP
      (NP (NN Figure) (CD 1))
      (: :)
      (S
        (NP
          (NP (NN Strategy))
          (PP (IN for)
            (S
              (VP (VBG Generating)
                (NP (NN Ews-ERG) (NN Invertor) (NN Gene))
                (PP (IN by)
                  (NP (JJ Homologous) (NN Recombination)))))))
        (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-))
        (NP
          (NP (DT The) (NN method))
          (PP (IN for)
            (S
              (VP (VBG making)
                (NP (NN invertor) (NNS mice))))))
        (VP (VBZ is)
          (VP (VBN described)
            (PP (IN in)
              (NP (NN detail)
                (QP (RB elsewhere) (CD -LSB-35))))))
        (-RRB- -RSB-))
      (. .))))

(
  (S
    (PP (IN In)
      (NP (NN summary)))
    (, ,)
    (NP
      (NP
        (NP
          (NP (DT an) (JJ invertor) (NN cassette))
          (VP (VBG comprising)
            (NP
              (NP (DT a) (JJ short) (JJ intronic) (NN region))
              (PP (IN with)
                (NP
                  (NP (DT an) (NN acceptor) (NN splice) (NN site))
                  (, ,)
                  (NP
                    (NP (JJ human) (NN ERG) (NN cDNA) (NN sequence))
                    (PRN (-LRB- -LRB-)
                      (VP (VBN shown)
                        (PP (IN in)
                          (NP (NN Figure) (NN S1))))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP (DT a) (NN polyA) (NN site))
                  (, ,))))))
        (CC and)
        (NP (DT the) (NN MC1neopA) (NN gene) (NN all)))
      (VP (VBN flanked)
        (PP (IN by)
          (NP
            (NP (JJ loxP) (NNS sites))
            (-LRB- -LRB-)
            (VP (VBN depicted)
              (PP (IN by)
                (NP (JJ black) (NNS triangles))))
            (-RRB- -RRB-)))))
    (VP (VBD was)
      (VP (VBD knocked)
        (PP (IN in))
        (, ,)
        (S
          (VP (VBG using)
            (NP (JJ homologous) (NN recombination))
            (, ,)
            (PP (IN into)
              (NP (NN Ews) (NN intron) (CD 8)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN transcription) (NN orientation))
        (PP (IN of)
          (NP (DT the) (VBN targeted) (NN ERG) (NN cDNA) (NN invertor) (NN cassette))))
      (VP (VBD was)
        (ADJP (JJ opposite)
          (PP (IN from)
            (NP
              (NP (DT that))
              (PP (IN of)
                (NP (DT the) (JJ endogenous) (NN Ews) (NN gene))))))
        (PP (IN after)
          (NP (JJ initial) (JJ homologous) (NN recombination)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Germ) (NN line) (NN carrier) (NNS mice))
        (PP (IN of)
          (NP (DT this) (VBN targeted) (NN allele))))
      (VP (VBD were)
        (VP (VBN crossed)
          (PP (IN with)
            (NP (JJ Cre-expressing) (NN mouse) (NNS strains) (CD -LSB-36) (-RRB- -RSB-))))))
    (, ,)
    (CC and)
    (S (, ,)
      (SBAR (IN as)
        (S
          (VP (VBN indicated)
            (PP (IN in)
              (NP
                (NP (DT the) (JJ right) (NN hand) (NN side))
                (PP (IN of)
                  (NP (DT the) (NN diagram))))))))
      (, ,)
      (NP (DT the) (NN invertor) (NN cassette))
      (VP (VBZ is)
        (VP (VBD turned)
          (SBAR (IN around)
            (S
              (VP (TO to)
                (VP (VB create)
                  (NP
                    (NP (DT a) (NN transcription) (NN orientation))
                    (ADJP (JJ identical)
                      (PP (IN with)
                        (NP
                          (NP (DT that))
                          (PP (IN of)
                            (NP (NN Ews))))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (PP (IN after)
        (NP (NN transcription)))
      (, ,)
      (NP (DT a) (NN pre-mRNA))
      (VP (VBZ is)
        (VP (VBN made)
          (PP (IN with)
            (NP
              (NP (DT the) (NN donor) (NN splice) (NN site))
              (PP (IN of)
                (NP (NN Ews) (NN exon) (CD 7)))
              (ADJP (JJ adjacent)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN acceptor) (NN site))
                    (PP (IN of)
                      (NP (DT the) (NN invertor) (NN cassette)))))))))
        (, ,)
        (S
          (VP (VBG allowing)
            (NP
              (NP (JJ post-transcriptional) (NN fusion))
              (PP (IN of)
                (NP (NN Ews)))
              (PP (IN with)
                (NP (NN ERG))))
            (PP (IN in)
              (NP
                (NP (DT an) (JJ analogous) (NN format))
                (PP (TO to)
                  (NP
                    (NP (DT that))
                    (VP (VBN found)
                      (PP (IN in)
                        (NP
                          (NP (JJ human) (NNS sarcomas))
                          (PP (IN with)
                            (NP (NN t) (-LRB- -LRB-) (CD 21) (: ;) (CD 22) (-RRB- -RRB-)))))))))))))
      (. .))
    (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-))))

(
  (S
    (S
      (NP
        (NP (JJ Genomic) (NN sequence))
        (ADJP (JJ adjacent)
          (PP (TO to)
            (NP
              (NP (DT the)
                (NP (NN Ews) (NN exon) (CD 7))
                (CC and)
                (NP (DT the) (NN ERG) (NN invertor) (NN cassette)))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (DT the) (VBN derived) (NN amino) (NN acid) (NN sequence))
                  (VP (VBZ is)
                    (VP (VBN shown)
                      (PP (IN in)
                        (NP
                          (NP (DT the) (JJ single) (NN letter))
                          (VP (VBP code)))))))
                (-RRB- -RRB-))))))
      (VP (VBN obtained)
        (PP (IN from)
          (NP
            (NP (NN DNA))
            (PP
              (PP (IN of)
                (NP (NN ES) (NNS cells)))
              (CC and)
              (PP (IN of)
                (NP (NN thymus))))))
        (PP (IN after)
          (NP (JJ Cre-mediated) (NN inversion)))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN Ews) (NN intron) (JJ 7/8) (NN donor) (NN splice) (NN site))
      (VP (VBZ is)
        (VP (VBN indicated)
          (PP (IN by)
            (NP (DT an) (NN arrow))))))
    (. .)))

(
  (S
    (NP
      (NP (DT The) (JJ boxed) (NN sequence))
      (-LRB- -LRB-))))

(
  (S
    (NP (NN TCTAG/))))

(
  (S
    (NP (NN CGAT) (-RRB- -RRB-))
    (VP (VBZ corresponds)
      (PP (TO to)
        (NP
          (NP (DT the) (NN ligation))
          (PP (IN of)
            (NP
              (NP (JJ filled-in)
                (NP
                  (NP
                    (NP (NN XbaI))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Ews) (JJ genomic))
                      (-RRB- -RRB-)))
                  (CC and)
                  (NP
                    (NP (NN ClaI))
                    (PRN (-LRB- -LRB-)
                      (NP (NN ERG) (NN invertor) (NN cassette))
                      (-RRB- -RRB-))))
                (NNS sites))
              (PRN (-LRB- -LRB-)
                (SBAR (IN for)
                  (S
                    (NP (JJ detailed) (NN description))
                    (VP (VB see)
                      (NP (CD -LSB-35) (-RRB- -RSB-)))))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (NP
      (NP (DT The) (JJ boxed) (NN XbaI) (NN site))
      (-LRB- -LRB-))))

(
  (S
    (NP (NN TCTAGA) (-RRB- -RRB-))
    (VP (VBZ corresponds)
      (PP (TO to)
        (NP
          (NP (DT the) (NN position))
          (PP (IN of)
            (NP
              (NP (NN cloning))
              (PP (IN of)
                (NP
                  (NP (DT the) (NN mouse) (NN Af4) (JJ intronic) (NN sequence))
                  (PRN (-LRB- -LRB-)
                    (NP (JJ shaded))
                    (-RRB- -RRB-))))))
          (PP (IN in)
            (NP (DT the) (NN ERG) (NN invertor) (NN cassette))))))
    (. .)))

(
  (S
    (PP (IN On)
      (NP
        (NP (DT the) (JJ 3′) (NN side))
        (PP (IN of)
          (NP (DT the) (VBN fused) (NN XbaI-ClaI) (NNS sites)))))
    (, ,)
    (NP (EX there))
    (VP (VBZ is)
      (NP
        (NP (DT a) (JJ loxP) (NN site))
        (VP (VBG originating)
          (PP (IN from)
            (NP
              (NP
                (NP (DT the) (JJ ERG) (NN invertor) (NN cassette))
                (PRN (-LRB- -LRB-)
                  (S
                    (VP (VB see)
                      (NP (NN Figure) (NN S1))))
                  (-RRB- -RRB-)))
              (VP (VBN followed)
                (PP (IN by)
                  (NP
                    (NP (DT the)
                      (NP
                        (NP (NN Af4) (NN intron) (CD 4))
                        (PRN (-LRB- -LRB-)
                          (NP (JJ shaded))
                          (-RRB- -RRB-))))
                    (ADVP (RB upstream)
                      (PP (IN of)
                        (NP (DT the) (NN ERG) (NN cDNA) (NN sequence))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN Af4) (NN acceptor) (NN splice) (NN site))
      (VP
        (VP (VBZ is)
          (VP (VBN indicated)
            (PP (IN by)
              (NP (DT an) (NN arrow)))))
        (, ,)
        (CC and)
        (VP (VBZ is)
          (VP (VBN followed)
            (PP (IN by)
              (NP (DT the) (NN ERG) (NN cDNA) (NN sequence)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (NNP NotI) (NN site))
        (VP (VBN used)
          (PP (IN for)
            (S
              (VP (VBG cloning)
                (NP (DT the) (VBN amplified) (NN ERG) (NN sequence)))))))
      (VP (VBZ is)
        (VP (VBN boxed)
          (PRN (-LRB- -LRB-)
            (S
              (VP (VB see)
                (ADVP (RB also))
                (NP (NN Figure) (NN S1))))
            (-RRB- -RRB-))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NN note))
              (PRN
                (S
                  (S
                    (NP (DT this) (NN sequence))
                    (VP (VBZ is)
                      (ADJP (JJ non-contiguous))))
                  (CC and)
                  (S
                    (NP (DT the) (NNS dots))
                    (VP (VBP represent)
                      (NP (DT a) (NN gap))))
                  (: ;)
                  (S
                    (NP (DT the) (JJ full) (NN sequence))
                    (VP (VBZ appears)
                      (PP (IN in)
                        (NP (NN -LSB-35))))))
                (-RRB- -RSB-)))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 2))
      (: :)
      (S
        (NP
          (NP
            (NP (NN Incidence))
            (PP (IN of)
              (NP (JJ Haematological) (NN Malignancy))))
          (CC and)
          (NP
            (NP (NNS Characteristics))
            (PP (IN of)
              (NP
                (NP (NNP Ews-ERG) (NNP Invertor) (NNP MiceCohorts))
                (PP (IN of)
                  (NP
                    (NP (CD 29) (NN Ews-ERG) (: ;) (NN Rag1-Cre) (NNS mice))
                    (CC and)
                    (NP (CD 20) (NN Ews-ERG) (NN control) (NNS mice))))))))
        (VP (VBD were)
          (VP (VBN monitored)
            (PP (IN over)
              (NP
                (NP (DT a) (NN period))
                (PP (IN of)
                  (NP
                    (QP (RB approximately) (CD 17))
                    (NN mo))))))))
      (. .))))

(
  (S
    (S
      (S
        (NP (NNS Mice))
        (VP (VBD were)
          (VP (VBN culled))))
      (CC and)
      (S
        (NP
          (NP (DT a) (NN post-mortem))
          (VP (VBN conducted)
            (PP (IN when)
              (NP
                (NP (NNS signs))
                (PP (IN of)
                  (NP (NN ill) (NN health)))))))
        (VP (VBD were)
          (VP (VBN observed)))))
    (. .)))

(
  (S
    (S
      (NP (NN Leukaemia/lymphoma))
      (VP (VBD was)
        (VP (VBN established)
          (PP (IN by)
            (NP
              (NP (JJ various) (NNS criteria))
              (PRN (-LRB- -LRB-)
                (NP (VB see)
                  (NP
                    (NP (NNS Materials))
                    (CC and)
                    (NP (NNS Methods))))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP (NN Top) (NN panel))
      (VP (VBZ shows)
        (NP
          (NP (DT the) (NN survival) (NN curve))
          (PP (IN of)
            (NP (NN Ews-ERG) (: ;) (NN Rag1-Cre) (-LRB- -LRB-) (NN +Cre) (-RRB- -RRB-)
              (CC or)
              (JJ Ews-ERG) (-LRB- -LRB-) (NN −Cre) (-RRB- -RRB-) (NNS mice))))
        (PP (IN as)
          (NP
            (NP (DT a) (NN function))
            (PP (IN of)
              (NP
                (NP (NN time))
                (PRN (-LRB- -LRB-)
                  (NP (NNS days))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Bottom) (NN panel))
      (VP (VBZ shows)
        (NP
          (NP (DT the) (NN histology))
          (PP (IN of)
            (NP
              (NP
                (NP (NN blood))
                (CC and)
                (NP (NN bone) (NN marrow)))
              (PP (IN from)
                (NP (JJ leukaemic) (NNS mice))))))
        (PRN (-LRB- -LRB-)
          (NP
            (NP
              (NP (NNP M21))
              (CC and)
              (NP (NNP M20)))
            (, ,)
            (ADVP (RB respectively)))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (NP (NN Blood) (NNS smears))
      (VP (VBD were)
        (VP
          (VP (VBN stained)
            (PP (IN with)
              (NP (NN May-Grünwald-Giemsa) (NN stain))))
          (CC and)
          (VP (VBN photographed)
            (PP (IN at)
              (NP (NN 400×) (NN magnification)))))
        (, ,)
        (SBAR (IN whilst)
          (S
            (NP (NN bone) (NN marrow))
            (VP (VBD was)
              (VP (VBN photographed)
                (PP (IN at)
                  (NP (NN 1,000×)))))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 3))
      (: :)
      (S
        (NP
          (NP (NN Clonality))
          (PP (IN of)
            (NP (NN T) (NN Cell) (NN Neoplasias) (NN inEws-ERG) (NN Invertor) (JJ MiceGenomic) (NN DNA))))
        (VP (VBD was)
          (VP (VBN prepared)
            (PP (IN from)
              (NP
                (NP (JJ various) (NNS tissues))
                (PP (IN of)
                  (NP
                    (NP (JJ invertor) (NNS mice))
                    (PP (IN with)
                      (NP (NN thymomas))))))))))
      (. .))))

(
  (S
    (S
      (NP (JJ Genomic) (NN analysis))
      (VP (VBD was)
        (VP (VBN carried)
          (PRT (RP out))
          (S
            (VP (VBG using)
              (NP (NN filter) (NN hybridisation))
              (S
                (VP
                  (VP (TO to)
                    (VP (VB assess)
                      (NP
                        (NP (DT the) (NN presence))
                        (PP (IN of)
                          (NP (DT the) (JJ inverted) (NN ERG) (NN cassette)))
                        (PP (IN in)
                          (NP
                            (NP (DT the) (NN tumour) (NNS cells))
                            (PRN (-LRB- -LRB-)
                              (NP (NN A))
                              (-RRB- -RRB-)))))))
                  (, ,)
                  (CC and)
                  (VP (TO to)
                    (VP (VB assess)
                      (SBAR (IN whether)
                        (S
                          (NP
                            (NP (DT the) (NNS lymphocytes))
                            (VP (VBN involved)
                              (PP (IN in)
                                (NP (DT the) (NNS tumours)))))
                          (VP (VBD were)
                            (NP
                              (NP
                                (NP
                                  (NP
                                    (NP
                                      (NP
                                        (NP (JJ clonal) (NN T))
                                        (PRN (-LRB- -LRB-)
                                          (NP (NN B))
                                          (-RRB- -RRB-)))
                                      (CC or)
                                      (NP (NN B) (NNS cells)))
                                    (PRN (-LRB- -LRB-)
                                      (NP (NN C))
                                      (-RRB- -RRB-)))
                                  (. .))
                                (PRN (-LRB- -LRB-)
                                  (NP (NN A))
                                  (-RRB- -RRB-)))
                              (NN Inversion) (NN hybridisation) (NN autoradiograph))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN DNA))
      (VP (VBD was)
        (VP
          (VP (VBN prepared)
            (PP (IN from)
              (NP
                (NP (DT the)
                  (NP (NN thymoma))
                  (CC and)
                  (NP (JJ other) (NNS tissues)))
                (PP (IN of)
                  (NP (NN M18))))))
          (, ,)
          (VP (VBN cleaved)
            (PP (IN with)
              (NP (NN EcoRI))))
          (CC and)
          (VP (VBN hybridised)
            (PP (TO to)
              (NP
                (NP (DT the) (JJ 5′) (NN Ews) (NN probe))
                (-LRB- -LRB-)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (VBZ detects)
                      (NP
                        (NP (DT a) (JJ 5-kb) (JJ targeted) (NN ERG) (NN cassette) (NN fragment))
                        (CC or)
                        (NP (DT a) (JJ 6.5-kb) (JJ Cre-inverted) (NN fragment))))))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN If)
        (S
          (NP (DT the) (NN ERG) (NN cassette))
          (VP (VBZ is)
            (VP (VBN inverted)
              (PP (IN by)
                (NP (NN Cre) (NN activity)))))))
      (, ,)
      (NP
        (NP (DT the) (NN size))
        (PP (IN of)
          (NP (DT the) (NN EcoRI) (NN fragment))))
      (VP (VBZ increases)
        (PP (IN from)
          (NP (DT the) (JJ initial) (JJ targeted) (NN gene) (NN size)))
        (, ,)
        (SBAR (IN as)
          (S
            (VP (VBN indicated)
              (PP (IN in)
                (NP
                  (NP (DT the) (NNS maps))
                  (PP (IN below)
                    (NP (DT the) (NN figure))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS data))
        (VP (VBN shown)))
      (VP (VBP are)
        (PP (IN for)
          (NP
            (NP (NN DNA))
            (VP (VBN extracted)
              (PP (IN from)
                (NP
                  (NP
                    (NP (NN spleen))
                    (PRN (-LRB- -LRB-)
                      (NP (NN spl))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (NN thymus))
                    (PRN (-LRB- -LRB-)
                      (NP (NN thy))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (NN liver))
                    (PRN (-LRB- -LRB-)
                      (NP (NN liv))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (NN kidney))
                    (PRN (-LRB- -LRB-)
                      (NP (NN kid))
                      (-RRB- -RRB-)))
                  (CC or)
                  (NP
                    (NP (NN tail))
                    (PRN (-LRB- -LRB-)
                      (S
                        (NP (NN ES) (NN cell) (NN DNA))
                        (VP (VBZ is)
                          (VP (VBN used)
                            (PP (IN as)
                              (NP (DT a) (NN control))))))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ Cre-mediated) (JJ inverted) (NN band))
        (PRN (-LRB- -LRB-)
          (NP (CD ∼6.5) (NN kb))
          (-RRB- -RRB-)))
      (VP (VBZ is)
        (ADJP (JJ evident)
          (PP (IN in)
            (NP
              (NP (NN thymus) (NN DNA))
              (PRN (-LRB- -LRB-)
                (NP (NN thymoma))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN summary))
        (PP (IN of)
          (NP
            (NP (DT the) (NNS data))
            (PP (IN from)
              (NP
                (NP (DT the) (NN cohort))
                (PP (IN of)
                  (NP (NN invertor) (NNS mice))))))))
      (VP (VBZ is)
        (PP (IN in)
          (NP (NN Table) (CD 2)))))
    (. .)))

(
  (S
    (S
      (VP (VB Note)
        (SBAR (IN that)
          (S
            (S
              (PP (IN despite)
                (NP
                  (NP (JJ extensive) (NN infiltration))
                  (PP (IN of)
                    (NP
                      (NP (NN spleen))
                      (VP (VBN detected)
                        (PP (IN by)
                          (NP (NN histology))))))))
              (, ,)
              (NP (PRP we))
              (ADVP (RB cannot))
              (VP (VB see)
                (NP
                  (NP (DT the) (JJ inverted) (NN band))
                  (PP (IN by)
                    (NP (NN Southern) (NN blot))))))
            (: ;)
            (S
              (NP (DT this))
              (ADVP (RB presumably))
              (VP (VBZ reflects)
                (NP
                  (NP (JJ regional) (NN clustering))
                  (PP (IN of)
                    (NP
                      (NP (JJ neoplastic) (NNS cells))
                      (PP (IN in)
                        (NP (NN spleen))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Restriction) (NN fragment) (NNS sizes))
      (VP (VBP are)
        (VP (VBN represented)
          (PP (IN as)
            (NP
              (NP
                (NP (NN germ) (NN line))
                (PRN (-LRB- -LRB-)
                  (NP (NN GL))
                  (-RRB- -RRB-)))
              (, ,)
              (NP
                (NP
                  (NP (JJ inverted) (NN allele))
                  (PP (IN of)
                    (NP
                      (NP (NN ERG) (NN cassette))
                      (PRN (-LRB- -LRB-)
                        (NP (NN inv))
                        (-RRB- -RRB-)))))
                (CC and)
                (NP
                  (NP (JJ initial) (JJ targeted) (NN Ews) (NN allele))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Tgt))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN organisation))
        (PP (IN of)
          (NP (DT the) (VBN targeted) (NN Ews) (NN allele))))
      (VP (VBZ is)
        (VP (VBN indicated)
          (NP (NN underneath)))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN hybridisation) (NN autoradiograph))
      (VP (VBZ shows)
        (NP
          (NP
            (NP (DT the) (NN location))
            (PP (IN of)
              (NP (NN Ews) (NN exon) (CD 7))))
          (CC and)
          (NP
            (NP
              (NP
                (NP (DT the) (JJ initial) (JJ targeted) (NN orientation))
                (PRN (-LRB- -LRB-)
                  (NP (NN bottom))
                  (-RRB- -RRB-)))
              (CC or)
              (NP (JJ inverted) (NN orientation)))
            (PP (IN of)
              (NP (NN ERG) (NN invertor) (NN cassette)))))
        (PP (IN after)
          (NP
            (NP (JJ Cre-mediated) (NN recombination))
            (PRN (-LRB- -LRB-)
              (NP (NN top))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (NP
      (NP (NN a))
      (, ,)
      (NP
        (NP (NN acceptor) (NN splice) (NN site.))
        (PRN (-LRB- -LRB-)
          (NP (NN B))
          (-RRB- -RRB-))))))

(
  (S
    (S
      (NP
        (NP (NN Autoradiograph))
        (VP (VBG showing)
          (NP
            (NP (NN rearrangement))
            (PP (IN of)
              (NP (NN T) (NN cell) (NN receptor))))))
      (VP (VBZ β)
        (NP (NN locus))))
    (. .)))

(
  (S
    (NP
      (NP
        (NP (DT A) (NN T) (NN cell) (NN receptor))
        (PRN (NN Jβ2) (NN probe) (NN -LSB-40) (-RRB- -RSB-)))
      (PRN (-LRB- -LRB-)
        (ADVP (RB diagrammatically))
        (VP (VBN shown)
          (PP (IN below)
            (NP (DT the) (NN autoradiograph))))
        (-RRB- -RRB-)))
    (VP (VBZ detects)
      (NP (DT a) (JJ 5-kb) (NN germ) (NN line) (NN HindIII) (NN Jβ2) (NN band))
      (SBAR (IN whilst)
        (S
          (NP
            (NP (NN V-D-Jβ2) (NNS joins))
            (PP (IN in)
              (NP (NN T) (NNS cells))))
          (VP (VBP result)
            (PP (IN in)
              (NP
                (NP (JJ new) (JJ HindIII-sized) (NNS bands))
                (PP (VBG depending)
                  (PP (IN on)
                    (NP
                      (NP (DT the) (NN nature))
                      (PP (IN of)
                        (NP (DT the) (NN rearrangement))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT Each))
        (PP (IN of)
          (NP
            (NP (CD 12) (NN thymoma) (NNS DNAs))
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VBD were)
                  (VP (VBN compared))))))))
      (VP (VBD showed)
        (NP
          (QP (CD one)
            (CC or)
            (CD two))
          (NN Jβ2) (NNS alleles) (JJ rearranged))
        (, ,)
        (S
          (VP (VBG signifying)
            (SBAR (IN that)
              (S
                (NP (DT these) (NNS tumours))
                (VP (VBD were)
                  (NP (JJ clonal) (NN T) (NNS cells)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT some) (NN thymoma) (NNS samples)))
      (, ,)
      (NP (EX there))
      (VP (VBZ is)
        (NP
          (NP
            (ADJP (RB almost) (JJ complete))
            (NN absence))
          (PP (IN of)
            (NP (DT the) (NN germ) (NN line) (NN band))))
        (, ,)
        (S
          (VP (VBG indicating)
            (SBAR (IN that)
              (S
                (NP
                  (NP (DT the) (NNS thymuses))
                  (PP (IN of)
                    (NP (DT these) (NNS mice))))
                (VP (VBP are)
                  (ADVP (RB solely))
                  (VP (VBN comprised)
                    (PP (IN of)
                      (NP (JJ malignant) (JJ clonal) (NN T) (NNS cells)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN DNA) (NN sequence) (NN analysis))
        (PP (IN of)
          (NP
            (NP (DT the) (NN V-D-J) (NNS junctions))
            (PP (IN of)
              (NP (NNS mice)
                (NP
                  (NP (NN M2))
                  (, ,)
                  (NP (NN M5))
                  (, ,)
                  (NP (NN M13))
                  (, ,)
                  (CC and)
                  (NP (NN M18))))))))
      (VP (VBD showed)
        (NP (JJ functional) (NN V-D-J) (NNS joins))
        (PRN (-LRB- -LRB-)
          (S
            (VP (VB see)
              (NP (NN Table) (CD 2))))
          (-RRB- -RRB-)))
      (. .))
    (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-))))

(
  (S
    (S
      (NP (NN Autoradiograph))
      (VP (VBG showing)
        (NP
          (NP (NN rearrangement) (NN status))
          (PP (IN of)
            (NP (NN immunoglobulin) (NN heavy-chain) (NNS genes))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (NN Cμ) (NN intron) (NN probe) (CD -LSB-41) (-RRB- -RSB-))
        (PRN (-LRB- -LRB-)
          (ADVP (RB diagrammatically))
          (VP (VBN shown)
            (PP (IN below)
              (NP (DT the) (NN autoradiograph))))
          (-RRB- -RRB-)))
      (VP (VBD was)
        (VP (VBN used)
          (S
            (VP (TO to)
              (VP (VB hybridise)
                (NP
                  (NP (DT a) (NN set))
                  (PP (IN of)
                    (NP (NN thymoma) (NNS DNAs))))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN presence))
                    (PP (IN of)
                      (NP (JJ Igh) (JJ rearranged) (NNS bands)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (QP (RB Only) (CD two))
        (NNS samples))
      (VP (VBD showed)
        (NP (NN rearrangements.))))
    (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-))))

(
  (S
    (NP
      (NP (NN Detection))
      (PP (IN of)
        (NP (NN Ews-Erg) (NN fusion) (NN protein)))
      (PP (IN in)
        (NP (NN thymoma) (NNS cells)))
      (. .))))

(
  (S
    (S
      (NP (JJ Single) (NN cell) (NNS suspensions))
      (VP (VBD were)
        (VP
          (VP (VBN made)
            (PP (IN of)
              (NP
                (NP (NN T) (NNS cells))
                (PP
                  (PP (IN from)
                    (NP
                      (NP (DT a) (JJ normal) (NN thymus))
                      (PRN (-LRB- -LRB-)
                        (NP (NN wt))
                        (-RRB- -RRB-))))
                  (CC or)
                  (PP (IN from)
                    (NP
                      (NP (DT the) (NN thymoma))
                      (PP (IN of)
                        (NP
                          (NP (NN M6))
                          (, ,)
                          (NP
                            (NP (NN protein))
                            (VP (VBN fractionated)
                              (PP (IN on)
                                (NP
                                  (ADJP
                                    (QP (CD 4) (NN %) (CD –20))
                                    (NN %))
                                  (NN acrylamide) (NN gel)))))
                          (, ,)))))))))
          (CC and)
          (VP (VBN transferred)
            (PP (TO to)
              (NP (NN nylon) (NNS membranes)))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Specific) (NNS proteins))
      (VP (VBD were)
        (VP (VBN detected)
          (PP (IN with)
            (NP
              (NP (NN anti-Ews))
              (CC or)
              (NP (NN anti-ERG) (NN antibody)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Figure) (CD 4))
        (: :)
        (S
          (NP
            (NP
              (NP (NN B))
              (CC and)
              (NP (NN T)))
            (NNS Cells))
          (VP (VBP Express)
            (NP
              (NP (DT the) (NN Ews-ERG) (NN Fusion) (NN RNAA) (JJ 96-d-old) (NN mouse))
              (PP (IN with)
                (NP (DT both) (NN Ews-ERG)
                  (CC and)
                  (NN Rag1-Cre) (NNS alleles)))))))
      (VP (VBD was)
        (VP (VBN used)
          (PP (IN as)
            (NP
              (NP (DT a) (NN source))
              (PP (IN of)
                (NP
                  (NP
                    (NP (NN spleen))
                    (CC and)
                    (NP (NN thymus)))
                  (NNS cells))))))))
    (. .)))

(
  (S
    (NP
      (NP (JJ Single) (NN cell) (NNS suspensions))
      (PP (IN of)
        (NP (NN spleen) (NNS cells))))
    (VP (VBD were)
      (VP (VBN labelled)
        (PP
          (PP (IN with)
            (NP (NN anti-B220)))
          (CC or)
          (PP (IN with)
            (NP (NN anti-Thy1.2))))))))

(
  (S
    (S (CC and)
      (VP (VBD were)
        (VP (VBN purified)
          (S
            (VP (VBG using)
              (NP (DT a) (NN MoFlo) (NN preparative) (NN flow) (NN cytometer)))))))
    (. .)))

(
  (S
    (S
      (NP (VBN Estimated) (NNS purities))
      (VP (VBD were)
        (VP (VBN achieved)
          (PP (IN of)
            (NP
              (QP (JJR greater) (IN than) (CD 95))
              (NN %))))))
    (. .)))

(
  (S
    (NP (NN cDNA))
    (VP (VBD was)
      (VP (VBN prepared)
        (PP (IN from)
          (NP
            (NP (NN RNA))
            (VP (VBN extracted)
              (PP
                (PP (IN from)
                  (NP (VBN sorted) (NNS cells)))
                (CC or)
                (PP (IN from)
                  (NP
                    (NP (NNS aliquots))
                    (PP (IN of)
                      (NP
                        (NP
                          (NP
                            (NP (JJ unsorted) (NNS populations))
                            (CC and)
                            (NP (NN RT-PCR)))
                          (PRN (-LRB- -LRB-)
                            (NP
                              (NP
                                (QP (RB approximately) (CD 3,400))
                                (NN B220+)
                                (CC or)
                                (CD 6,400) (NN Thy1.2+) (NN cell) (NNS equivalents))
                              (PP (IN per)
                                (NP (NN PCR) (NN reaction))))
                            (-RRB- -RRB-)))
                        (VP (VBN carried)
                          (PRT (RP out))
                          (PP (IN with)
                            (NP
                              (NP
                                (NP (JJ specific) (NN Pax5))
                                (PRN (-LRB- -LRB-)
                                  (NP (NN A))
                                  (-RRB- -RRB-)))
                              (, ,)
                              (NP
                                (NP (NN CD3))
                                (PRN (-LRB- -LRB-)
                                  (NP (NN B))
                                  (-RRB- -RRB-)))
                              (CC or)
                              (NP
                                (NP (NN Ews-ERG))
                                (PRN (-LRB- -LRB-)
                                  (NP (NN C))
                                  (-RRB- -RRB-)))
                              (NP (NNS primers)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN PCR) (NN reaction) (NNS products))
      (VP (VBD were)
        (VP
          (VP (VBN fractionated)
            (PP (IN on)
              (NP
                (NP
                  (NP
                    (ADJP (CD 1) (NN %))
                    (NN agarose) (NNS gels))
                  (CC and)
                  (NP (DT either)))
                (VP (VBN stained)
                  (PP (IN with)
                    (NP (NN ethidium) (NN bromide)))))))
          (CC and)
          (VP (VBN photographed)
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NN A))
                (CC and)
                (NP (NN B)))
              (-RRB- -RRB-))))))
    (CC or)
    (S
      (NP (NN gel))
      (VP
        (VP (VBN blotted))
        (CC and)
        (VP (VBN hybridised)
          (PP (IN with)
            (NP (DT an) (NN Ews-ERG) (NN probe))))))
    (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-))))

(
  (S
    (NP
      (NP (NN Figure) (CD 5))
      (: :)
      (S
        (S
          (NP
            (NP (NN Analysis))
            (PP (IN of)
              (NP
                (NP (NN Cell) (NN Surface) (NNS Antigens))
                (PP (IN of)
                  (NP
                    (NP (NN Thymomas))
                    (PP (IN from)
                      (NP (NN Ews-ERG) (NN Invertor) (NNS Mice)))))))
            (VP (VBG Using)
              (NP (NN Flow) (NN CytometryThymus) (NN tissue))))
          (VP (VBD was)
            (ADJP (JJ resected)
              (PP (IN from)
                (NP
                  (NP (NNS mice))
                  (PP (IN with)
                    (NP (NN thymoma))))))))
        (CC and)
        (S
          (NP (NN FACS) (NN analysis))
          (VP (VBN performed)
            (S
              (VP (TO to)
                (VP (VB determine)
                  (NP
                    (NP (NN T) (NN cell) (NN phenotype))
                    (-LRB- -LRB-)
                    (VP (VBN summarised)
                      (PP (IN in)
                        (NP (NN Table) (CD 1))))
                    (-RRB- -RRB-))))))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS data))
        (PP (IN in)
          (NP (DT the) (NN figure))))
      (VP (VBP show)
        (NP
          (NP (JJ representative) (NN flow) (NNS diagrams))
          (PP (IN of)
            (NP
              (NP (CD three) (JJ tumour-bearing) (NNS mice))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN M2))
                  (, ,)
                  (NP (NN M3))
                  (, ,)
                  (CC and)
                  (NP (NN M4)))
                (-RRB- -RRB-)))))
        (PP (VBN compared)
          (PP (IN with)
            (NP
              (NP (DT a) (JJ wild-type) (NN C57BL/6) (NN control))
              (PRN (-LRB- -LRB-)
                (NP (NN wt))
                (-RRB- -RRB-)))))
        (, ,)
        (S
          (VP
            (VP (VBG using)
              (NP
                (NP
                  (NP (NN anti-Thy1))
                  (PRN (-LRB- -LRB-)
                    (NP (NN y-axis))
                    (-RRB- -RRB-)))
                (CC plus)
                (NP (NN anti-B220) (-LRB- -LRB-) (NN x-axis) (-RRB- -RRB-) (NNS antibodies))))
            (CC or)
            (VP (VBG using)
              (NP (JJ anti-CD8) (-LRB- -LRB-) (NN y-axis) (-RRB- -RRB-)
                (CC plus)
                (JJ anti-CD4) (-LRB- -LRB-) (NN x-axis) (-RRB- -RRB-) (NNS antibodies)))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT The) (CD three) (NNS thymomas))
        (VP (VBP show)
          (NP
            (NP (DT a) (NN range))
            (PP (IN of)
              (NP
                (NP
                  (NP
                    (NP (NN CD4))
                    (CC and)
                    (NP (NN CD8)))
                  (NN co-expression) (NNS phenotypes))
                (VP (VBG characterizing)
                  (NP
                    (NP (DT the) (NNS thymomas))
                    (VP (VBN generated)
                      (PP (IN in)
                        (NP (DT the) (NN Ews-ERG) (: ;) (NN Rag1-Cre) (JJ invertor) (NNS mice)))))))))))
      (. .))
    (. .)))

(
  (S
    (NP
      (NP (NN Table) (CD 1))
      (: :)
      (NP
        (NP (NN Tumour) (NNS Characteristics))
        (PP (IN of)
          (NP
            (NP (NN Ews-ERG) (NN Invertor) (NNS Mice))
            (VP (VBG Expressing)
              (NP
                (NP (NN Cre) (NN Recombinase))
                (PP (IN from)
                  (NP (DT the) (NN Rag1) (NN Gene)))))))))))

(
  (S
    (NP
      (NP (NN Table) (CD 2))
      (: :)
      (NP
        (NP (NNS Sequences))
        (PP (IN of)
          (NP (JJ Rearranged) (NN TCR) (NN Jβ) (NNS Loci)))
        (PP (IN in)
          (NP (NN Ews-ERG) (NN Thymoma) (NN DNA)))))))

